<SEC-DOCUMENT>0001114446-26-002945.txt : 20260507
<SEC-HEADER>0001114446-26-002945.hdr.sgml : 20260507
<ACCEPTANCE-DATETIME>20260507170201
ACCESSION NUMBER:		0001114446-26-002945
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		14
FILED AS OF DATE:		20260507
DATE AS OF CHANGE:		20260507

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UBS AG
		CENTRAL INDEX KEY:			0001114446
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283672
		FILM NUMBER:		26954704

	BUSINESS ADDRESS:	
		STREET 1:		BAHNHOFSTRASSE 45
		CITY:			ZURICH
		STATE:			V8
		ZIP:			CH 8001
		BUSINESS PHONE:		203-719-5241

	MAIL ADDRESS:	
		STREET 1:		600 WASHINGTON BLVD.
		CITY:			STAMFORD
		STATE:			CT
		ZIP:			06901
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>tc11129324f_424b2.htm
<DESCRIPTION>TC11129324F_424B2.HTM
<TEXT>

<HTML>
<head>
</head>
<body marginwidth="10px" vlink="#FF6600" alink="#FF6600" bgcolor="#ffffff" leftmargin="0" topmargin="0" link="#FF6600" text="#000000" marginheight="0">
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="37.6%">
<p align="left">
</p>
</td><td width="30%">
<p align="left" style="color: rgb(251, 0, 0); font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; space-after: 3pt; space-before: 0pt;">
<b></b>
</p>
</td><td width="32.4%">
<p align="left">
</p>
</td>
</tr>
<tr>
<td width="37.6%">
<p align="left">
<img width="180px" alt="Logo" src="img_0.jpg" height="80px"></p>
</td><td width="30%">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;"> PRICING SUPPLEMENT</p>
<p align="left" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">Dated May 7, 2026</p>
<p align="left" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">Filed Pursuant to Rule 424(b)(2)</p>
<p align="left" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">Registration Statement No. 333-283672</p>
<p align="left" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">(To Prospectus dated February 6, 2025 and Product Supplement dated February 6, 2025)</p>
</td><td width="32.4%">
<p>
</p>
</td>
</tr>
</table>
<h3 style="color: rgb(0, 0, 0); font-family: Frutiger 45 Light; font-size: 13pt; font-weight: bold; space-after: 0pt; space-before: 0pt;" id="N1007C">UBS AG $350,000 Trigger Autocallable Contingent Yield Notes</h3>
<p style="font-family: Frutiger 45 Light; font-size: 10pt; font-weight: normal; line-height: normal; margin-left: 1pt; margin-top: 1pt; space-after: 3pt;">Linked to the common stock of Apollo Global Management, Inc. due May 11, 2027</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h2 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N100AD">Investment Description</h2>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 0pt; line-height: 0pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">UBS AG Trigger Autocallable Contingent Yield Notes (the &ldquo;Notes&rdquo;) are unsubordinated, unsecured debt obligations issued by UBS AG (&ldquo;UBS&rdquo; or the &ldquo;issuer&rdquo;) linked to the common stock of Apollo Global Management, Inc. (the "underlying asset").  UBS will pay a contingent coupon on the coupon payment date only if the closing level of the underlying asset on the applicable observation date (including the final valuation date) is equal to or greater than the coupon barrier. Otherwise, no contingent coupon will be paid for the relevant coupon payment date. UBS will automatically call the Notes early if the closing level of the underlying asset on any observation date prior to the final valuation date is equal to or greater than the initial level. If the Notes are subject to an automatic call, UBS will pay you on the coupon payment date corresponding to such observation date (the &ldquo;call settlement date&rdquo;) a cash payment per Note equal to the principal amount plus any contingent coupon otherwise due, and no further payments will be owed to you under the Notes. If the Notes are not subject to an automatic call and the closing level of the underlying asset on the final valuation date (the &ldquo;final level&rdquo;) is equal to or greater than the downside threshold, at maturity, UBS will pay you a cash payment per Note equal to the principal amount. If, however, the Notes are not subject to an automatic call and the final level is less than the downside threshold, at maturity, UBS will pay you a cash payment per Note that is less than the principal amount, if anything, resulting in a percentage loss on your initial investment equal to the percentage decline in the underlying asset from the initial level to the final level (the &ldquo;underlying return&rdquo;) and, in extreme situations, you could lose all of your initial investment. <b>Investing in the Notes involves significant risks. You may lose a significant portion or all of your initial investment and may not receive any contingent coupons during the term of the Notes. Generally, a higher contingent coupon rate on a Note is associated with a greater risk of loss and a greater risk that you will not receive contingent coupons over the term of the Notes. The contingent repayment of principal applies only at maturity. Any payment on the Notes, including any repayment of principal, is subject to the creditworthiness of UBS. If UBS were to default on its obligations you may not receive any amounts owed to you under the Notes and you could lose all of your initial investment.</b>
</p>
<div style="float: left; width: 49%;">
<p style="font-family: Frutiger 45 Light; font-size: 0pt; line-height: 0pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h2 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N10101">Features</h2>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="3%">
<p style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">&bull;</p>
</td><td width="97%">
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">
<b>Potential for Periodic Contingent Coupons  &mdash; </b> UBS will pay a contingent coupon on the related coupon payment date if the closing level of the underlying asset is equal to or greater than the coupon barrier on an observation date (including the final valuation date). Otherwise, if the closing level of the underlying asset is less than the coupon barrier on an observation date, no contingent coupon will be paid for the relevant coupon payment date.</p>
</td>
</tr>
<tr height="1.56104164322217cm">
<td width="3%">
<p style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">&bull;</p>
</td><td width="97%">
<p style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">
<b>Automatic Call Feature &mdash; </b>UBS will automatically call the Notes and pay you the principal amount of your Notes plus the contingent coupon otherwise due on the related coupon payment date if the closing level of the underlying asset is equal to or greater than the initial level on any observation date  prior to the final valuation date. If the Notes were previously subject to an automatic call, no further payments will be owed to you under the Notes. If the Notes are not subject to an automatic call, you will have the potential for downside market risk at maturity.</p>
</td>
</tr>
<tr height="1.56104164322217cm">
<td width="3%">
<p style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">&bull;</p>
</td><td width="97%">
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">
<b>Contingent Repayment of Principal at Maturity with Potential for Full Downside Market Exposure &mdash; </b>If  the Notes are not subject to an automatic call and the final level is equal to or greater than the downside threshold, at maturity, UBS will pay you a cash payment per Note equal to the principal amount. If, however, the Notes are not subject to an automatic call and the final level is less than the downside threshold, at maturity, UBS will pay you a cash payment per Note that is less than the principal amount, if anything, resulting in a percentage loss on your initial investment equal to the underlying return and, in extreme situations, you could lose all of your initial investment. The contingent repayment of principal applies only if you hold the Notes to maturity. Any payment on the Notes, including any repayment of principal, is subject to the creditworthiness of UBS.</p>
</td>
</tr>
</table>
</div>
<div style="float: right; width: 49%;">
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h2 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N10190">Key Dates</h2>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="40%">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">Trade Date*</p>
</td><td width="60%">
<p align="right" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">May 7, 2026</p>
</td>
</tr>
<tr>
<td width="40%">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">Settlement Date*</p>
</td><td width="60%">
<p align="right" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">May 11, 2026</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="40%">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">Observation Dates**</p>
</td><td width="60%">
<p align="right" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">Quarterly (see page 4)</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="40%">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">Final Valuation Date**</p>
</td><td width="60%">
<p align="right" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">May 7, 2027</p>
</td>
</tr>
<tr height="0.423333326975505cm">
<td width="40%">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">Maturity Date**</p>
</td><td width="60%">
<p align="right" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">May 11, 2027</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 0pt; line-height: 0pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">*We expect to deliver the Notes against payment on the second business day following the trade date. Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), trades in the secondary market generally are required to settle in one business day (T+1), unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes in the secondary market on any date prior to one business day before delivery of the Notes will be required, by virtue of the fact that each Note initially will settle in two business days (T+2), to specify alternative settlement arrangements to prevent a failed settlement of the secondary market trade.</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">**Subject to postponement in the event of a market disruption event, as described in the accompanying product supplement.</p>
<p style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">
</p>
</div>
<div style="margin:auto; width: 2%;">
<p></p>
</div>
<br clear="all">
<div style="width: 100%;">
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">
<b>Notice to investors: the Notes are significantly riskier than conventional debt instruments. The issuer is not necessarily obligated to repay the principal amount of the Notes at maturity, and the Notes may have the same downside market risk as that of the underlying asset. This market risk is in addition to the credit risk inherent in purchasing a debt obligation of UBS. You should not purchase the Notes if you do not understand or are not comfortable with the significant risks involved in investing in the Notes.</b>
</p>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">
<b>You should carefully consider the risks described under &ldquo;Key Risks&rdquo; beginning on page 5 and under &ldquo;Risk Factors&rdquo; beginning on page PS-9 of the accompanying product supplement. Events relating to any of those risks, or other risks and uncertainties, could adversely affect the market value of, and the return on, your Notes. You may lose a significant portion or all of your initial investment in the Notes. The Notes will not be listed or displayed on any securities exchange or any electronic communications network.</b>
</p>
<p style="font-family: Frutiger 45 Light; font-size: 0pt; line-height: 0pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h2 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N102C5">Note Offering</h2>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 0pt; line-height: 0pt;">&nbsp;</p>
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">The Notes are offered at a minimum investment of 100 Notes at $10 per Note (representing a $1,000 investment), and integral multiples of $10 in excess thereof. </p>
<table cellspacing="0" width="100%" style="font-family: Frutiger 45 Light; font-size: 9pt; font-weight: normal; line-height: normal; margin-left: 1pt;" cellpadding="0">
<tr>
<td width="15.340086830680175%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Underlying Asset</b>
</p>
</td><td width="9.26193921852388%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Bloomberg Ticker</b>
</p>
</td><td width="11.287988422575976%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Contingent Coupon Rate</b>
</p>
</td><td width="10.274963820549928%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Initial Level</b>
</p>
</td><td width="12.301013024602026%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Downside Threshold</b>
</p>
</td><td width="13.16931982633864%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Coupon Barrier</b>
</p>
</td><td width="11.432706222865415%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>    CUSIP</b>
</p>
</td><td width="16.931982633863964%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>ISIN</b>
</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="15.340086830680175%">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">Common stock of Apollo Global Management, Inc.</p>
</td><td width="9.26193921852388%">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">APO</p>
</td><td width="11.287988422575976%">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">16.53% per annum </p>
</td><td width="10.274963820549928%">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">$127.79</p>
</td><td width="12.301013024602026%">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">$89.45, which is 70.00% of the Initial Level</p>
</td><td width="13.16931982633864%">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">$89.45, which is 70.00% of the Initial Level</p>
</td><td width="11.432706222865415%">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">90311R709</p>
</td><td width="16.931982633863964%">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">US90311R7098</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="10.6%" style="border-top-color:black;border-top-style:solid;border-top-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">&nbsp;</p>
</td><td width="6.4%" style="border-top-color:black;border-top-style:solid;border-top-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">&nbsp;</p>
</td><td width="7.8%" style="border-top-color:black;border-top-style:solid;border-top-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">&nbsp;</p>
</td><td width="7.1%" style="border-top-color:black;border-top-style:solid;border-top-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">&nbsp;</p>
</td><td width="12.7%" style="border-top-color:black;border-top-style:solid;border-top-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">&nbsp;</p>
</td><td width="8.5%" style="border-top-color:black;border-top-style:solid;border-top-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">&nbsp;</p>
</td><td width="9.1%" style="border-top-color:black;border-top-style:solid;border-top-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">&nbsp;</p>
</td><td width="9.1%" style="border-top-color:black;border-top-style:solid;border-top-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">&nbsp;</p>
</td><td width="9.1%" style="border-top-color:black;border-top-style:solid;border-top-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">&nbsp;</p>
</td><td width="7.9%" style="border-top-color:black;border-top-style:solid;border-top-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">&nbsp;</p>
</td><td width="11.7%" style="border-top-color:black;border-top-style:solid;border-top-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">&nbsp;</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 0pt; line-height: 0pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">The estimated initial value of the Notes as of the trade date is $9.77. The estimated initial value of the Notes was determined as of the close of the relevant markets on the date hereof by reference to UBS&rsquo; internal pricing models, inclusive of the internal funding rate. For more information about secondary market offers and the estimated initial value of the Notes, see &ldquo;Key Risks &mdash; Estimated Value Considerations&rdquo; and &ldquo;Risks Relating to Liquidity and Secondary Market Price Considerations&rdquo; beginning on page 5 herein.</p>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">
<b>See &ldquo;Additional Information About UBS and the Notes&rdquo; on page ii. The Notes will have the terms set forth in the accompanying product supplement relating to the Notes dated February 6, 2025, the accompanying prospectus dated February 6, 2025 and this document.</b>
</p>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">
<b>Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these Notes or passed upon the adequacy or accuracy of this document, the accompanying product supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense. </b>
</p>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">The Notes are not bank deposits and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency.</p>
<table cellspacing="0" width="100%" style="font-family: Frutiger 45 Light; font-size: 9pt; font-weight: normal; line-height: normal; margin-left: 1pt;" cellpadding="0">
<tr>
<td width="28%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Offering of Notes</b>
</p>
</td><td width="24%" colspan="2" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Issue Price to Public</b>
</p>
</td><td width="24%" colspan="2" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Underwriting Discount(1)</b>
</p>
</td><td width="24%" colspan="2" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Proceeds to UBS AG(1)</b>
</p>
</td>
</tr>
<tr>
<td width="28%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
</p>
</td><td width="12%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Total</b>
</p>
</td><td width="12%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Per Note</b>
</p>
</td><td width="12%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Total</b>
</p>
</td><td width="12%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Per Note</b>
</p>
</td><td width="12%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Total</b>
</p>
</td><td width="12%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">
<b>Per Note</b>
</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" style="font-family: Frutiger 45 Light; font-size: 9pt; font-weight: normal; line-height: normal; margin-left: 1pt;" cellpadding="0">
<tr>
<td width="28%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">Notes linked to the common stock of Apollo Global Management, Inc.</p>
</td><td width="12%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">$350,000.00</p>
</td><td width="12.21%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">$10.00</p>
</td><td width="11.79%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">$5,250.00</p>
</td><td width="12%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">$0.15</p>
</td><td width="12%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="left" style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">$344,750.00</p>
</td><td width="12%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="font-family: Frutiger 45 Light; font-size: 6pt; line-height: normal; font-weight: normal; space-before: 0pt; padding-top: 1pt;">$9.85</p>
</td>
</tr>
</table>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 6pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">(1) See &ldquo;Supplemental Plan of Distribution (Conflicts of Interest); Secondary Markets (if any)&rdquo; for additional information.</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="50%">
<h3 style="color: rgb(0, 0, 0); font-family: Frutiger 45 Light; font-size: 10pt; font-weight: bold; space-after: 0pt; space-before: 0pt;" id="N10535" align="left">UBS Financial Services Inc.</h3>
</td><td width="50%">
<h3 style="color: rgb(0, 0, 0); font-family: Frutiger 45 Light; font-size: 10pt; font-weight: bold; space-after: 0pt; space-before: 0pt;" id="N1053B" align="right">UBS Investment Bank</h3>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h2 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N1055E">Additional Information About UBS and the Notes</h2>
</td>
</tr>
</table>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">UBS has filed a registration statement (including a prospectus, as supplemented by a product supplement for the Notes) with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;), for the offering to which this document relates. You should read these documents and any other documents relating to the Notes that UBS has filed with the SEC for more complete information about UBS and this offering. You may obtain these documents for free from the SEC website at sec.gov. Our Central Index Key, or CIK, on the SEC website is 0001114446.</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>You may access these documents on the SEC website at sec.gov as follows:</b>
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull; Market-Linked Securities product supplement dated February 6, 2025:</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<u>http://www.sec.gov/Archives/edgar/data/1114446/000183988225007685/ubs_424b2-03670.htm</u>
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull; Prospectus dated February 6, 2025:</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<u>http://www.sec.gov/Archives/edgar/data/1114446/000119312525021845/d936490d424b3.htm</u>
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">References to &ldquo;UBS&rdquo;, &ldquo;we&rdquo;, &ldquo;our&rdquo; and &ldquo;us&rdquo; refer only to UBS AG and not to its consolidated subsidiaries. In this document, &ldquo;Trigger Autocallable Contingent Yield Notes&rdquo; or the &ldquo;Notes&rdquo; refer to the Notes that are offered hereby. Also, references to the &ldquo;accompanying product supplement&rdquo; or &ldquo;Market-Linked Securities product supplement&rdquo; mean the UBS product supplement, dated February 6, 2025 and references to the &ldquo;accompanying prospectus&rdquo; mean the UBS prospectus, titled &ldquo;Debt Securities and Warrants&rdquo;, dated February 6, 2025.</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">This document, together with the documents listed above, contains the terms of the Notes and supersedes all other prior or contemporaneous oral statements as well as any other written materials including all other prior pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other things, the matters set forth in &ldquo;Key Risks&rdquo; herein and in &ldquo;Risk Factors&rdquo; in the accompanying product supplement, as the Notes involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisors concerning an investment in the Notes.</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">If there is any inconsistency between the terms of the Notes described in the accompanying prospectus, the accompanying product supplement and this document, the following hierarchy will govern: first, this document; second, the accompanying product supplement; and last, the accompanying prospectus.</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">UBS reserves the right to change the terms of, or reject any offer to purchase, the Notes prior to their issuance. In the event of any changes to the terms of the Notes, UBS will notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes in which case UBS may reject your offer to purchase.</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="center" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">ii</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h1 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N10607">Investor Suitability</h1>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 0pt; line-height: 0pt;">&nbsp;</p>
</div>
<div style="float: left; width: 49%;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>The Notes may be suitable for you if:</b>
</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You fully understand the risks inherent in an investment in the Notes, including the risk of loss of a significant portion or all of your initial investment.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You can tolerate a loss of a significant portion or all of your initial investment and are willing to make an investment that may have the same downside market risk as an investment in the underlying asset.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You are willing to receive few or no contingent coupons and believe that the closing level of the underlying asset will be equal to or greater than the coupon barrier on each observation date and that the final level will be equal to or greater than the downside threshold.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You understand and accept that you will not participate in any appreciation in the level of the underlying asset and that your potential return is limited to any contingent coupons.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You can tolerate fluctuations in the price of the Notes prior to maturity that may be similar to or exceed the downside fluctuations in the level of the underlying asset.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You are willing to invest in the Notes based on the contingent coupon rate specified on the cover hereof.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You are willing to invest in the Notes based on the downside threshold and coupon barrier specified on the cover hereof.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You do not seek guaranteed current income from your investment and are willing to forgo any dividends paid on the underlying asset.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You are willing to invest in Notes that may be subject to an automatic call and you are otherwise willing to hold such Notes to maturity and you accept that there may be little or no secondary market for the Notes.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You understand and are willing to accept the risks associated with the underlying asset.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You are willing to assume the credit risk of UBS for all payments under the Notes, and understand that if UBS defaults on its obligations you may not receive any payments due to you including any repayment of principal.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You understand that the estimated initial value of the Notes determined by our internal pricing models is lower than the issue price and that should UBS Securities LLC or any affiliate make secondary markets for the Notes, the price (not including their customary bid-ask spreads) will temporarily exceed the internal pricing model price.</p>
</td>
</tr>
</table>
</div>
<div style="float: left; width: 49%;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>The Notes may not be suitable for you if:</b>
</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You do not fully understand the risks inherent in an investment in the Notes, including the risk of loss of a significant portion or all of your initial investment.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You require an investment designed to provide a full return of principal at maturity.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You cannot tolerate a loss of a significant portion or all of your initial investment or you are not willing to make an investment that may have the same downside market risk as an investment in the underlying asset.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You are unwilling to receive few or no contingent coupons during the term of the Notes or believe that the closing level of the underlying asset will decline during the term of the Notes and is likely to be less than the coupon barrier on each observation date or that the final level will be less than the downside threshold.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You seek an investment that participates in the appreciation in the level of the underlying asset or that has unlimited return potential.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You cannot tolerate fluctuations in the price of the Notes prior to maturity that may be similar to or exceed the downside fluctuations in the level of the underlying asset.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You are unwilling to invest in the Notes based on the contingent coupon rate specified on the cover hereof.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You are unwilling to invest in the Notes based on the downside threshold or coupon barrier specified on the cover hereof.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You seek guaranteed current income from your investment or prefer to receive any dividends paid on the underlying asset.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You are unable or unwilling to hold Notes that may be subject to an automatic call, or you are otherwise unable or unwilling to hold such Notes to maturity or you seek an investment for which there will be an active secondary market.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You do not understand or are unwilling to accept the risks associated with the underlying asset.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="4.65%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&bull;</p>
</td><td width="95.35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">You are not willing to assume the credit risk of UBS for all payments under the Notes, including any repayment of principal.</p>
</td>
</tr>
</table>
</div>
<div style="margin:auto; width: 2%;">
<p></p>
</div>
<br clear="all">
<div style="width: 100%;">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>The suitability considerations identified above are not exhaustive. Whether or not the Notes are a suitable investment for you will depend on your individual circumstances. You are urged to consult your investment, legal, tax, accounting and other advisors and carefully consider the suitability of an investment in the Notes in light of your particular circumstances. You should review &ldquo;Information About the Underlying Asset &rdquo; herein for more information on the underlying asset. You should also review carefully the &ldquo;Key Risks&rdquo; section herein for risks related to an investment in the Notes.</b>
</p>
<p></p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h1 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N1090E">Final Terms</h1>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 0pt; line-height: 0pt;">&nbsp;</p>
</div>
<div style="float: left; width: 49%;">
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Issuer:</p>
</td><td width="70%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">UBS AG, London Branch</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Principal Amount:</p>
</td><td width="70%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">$10 per Note</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Term:</p>
</td><td width="70%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Approximately 1 year, unless subject to an automatic call.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Underlying Asset:</p>
</td><td width="70%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">The common stock of Apollo Global Management, Inc.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Contingent Coupon and Contingent Coupon Rate:</p>
</td><td width="70%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>If the closing level of the underlying asset is equal to or greater than the coupon barrier on any observation date (including the final valuation date),</b> UBS will pay you the contingent coupon applicable to such observation date on the related coupon payment date.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>If the closing level of</b> <b>the</b> <b>underlying asset is less than the coupon barrier on any observation date (including the final valuation date)</b>, the contingent coupon applicable to such observation date will not accrue or be payable and UBS will not make any payment to you on the relevant coupon payment date.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">The contingent coupon is a fixed amount based upon equal periodic installments at a per annum rate (the &ldquo;contingent coupon rate&rdquo;). The table below sets forth the contingent coupon rate and contingent coupon for each Note that would be applicable to each observation date on which the above conditions are satisfied.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&nbsp;</p>
</td><td width="35%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Contingent Coupon Rate</b>
</p>
</td><td width="35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">16.53% per annum</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&nbsp;</p>
</td><td width="35%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Contingent Coupon</b>
</p>
</td><td width="35%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">$0.4133</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&nbsp;</p>
</td><td width="70%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Contingent coupons on the Notes are not guaranteed. UBS will not pay you the contingent coupon for any observation date on which the closing level of the underlying asset is less than the coupon barrier.</b>
</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Automatic Call Feature:</p>
</td><td width="70%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">UBS will automatically call the Notes if the closing level of the underlying asset on any observation date other than the final valuation date is equal to or greater than the initial level. </p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">If the Notes are subject to an automatic call, UBS will pay you on the corresponding coupon payment date (the &ldquo;call settlement date&rdquo;) a cash payment per Note equal to your principal amount plus any contingent coupon otherwise due (the &ldquo;call settlement amount&rdquo;). Following an automatic call, no further payments will be made on the Notes.</p>
</td>
</tr>
</table>
</div>
<div style="float: right; width: 49%;">
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Payment at Maturity (per Note):</p>
</td><td width="70%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>If the Notes are not subject to an automatic call and the final level is equal to or greater than the downside threshold</b>, UBS will pay you a cash payment equal to: </p>
<p align="center" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Principal Amount of $10</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>If the Notes are not subject to an automatic call and the final level is less than its downside threshold, </b>UBS will pay you a cash payment that is less than the principal amount, if anything, equal to:</p>
<p align="center" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">$10 x (1+ Underlying Return)</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>In this scenario, you will suffer a percentage loss on your initial investment equal to the underlying return and, in extreme situations, you could lose all of your initial investment.</b>
</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Underlying Return:</p>
</td><td width="70%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">The quotient, expressed as a percentage, of the following formula:</p>
<p align="center" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<img width="85px" alt="Formula" src="img_1.jpg" height="17px"></p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Downside Threshold:(1)</p>
</td><td width="70%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">A specified level of the underlying asset that is less than the initial level, equal to a percentage of the initial level, as specified on the cover hereof. </p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Coupon Barrier:(1)</p>
</td><td width="70%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">A specified level of the underlying asset that is less than the initial level, equal to a percentage of the initial level, as specified on the cover hereof. </p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Initial Level:(1)</p>
</td><td width="70%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">The closing level of the underlying asset on the trade date, as specified on the cover hereof.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Final Level:(1)</p>
</td><td width="70%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">The closing level of the underlying asset on the final valuation date.</p>
</td>
</tr>
</table>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">(1) As determined by the calculation agent and as may be adjusted in the case of certain adjustment events as described under &ldquo;General Terms of the Securities &mdash; Antidilution Adjustments for Securities Linked to an Underlying Equity or Equity Basket Asset&rdquo;, &ldquo;Reorganization Events for Securities Linked to an Underlying Equity or Equity Basket Asset&rdquo; and &ldquo;Delisting of, Suspension of Trading in, or Change in Law Affecting, an Underlying Equity&rdquo; in the accompanying product supplement.</p>
</div>
<div style="margin:auto; width: 2%;">
<p></p>
</div>
<br clear="all">
<div style="width: 100%;">
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h1 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N10B71">Investment Timeline</h1>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 0pt; line-height: 0pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="25%" rowspan="3">
<p></p>
<p>
<img width="106px" alt="Investment Timeline Image_LUMA" src="img_2.jpg" height="370px"></p>
<p>&nbsp;</p>
</td><td width="1%" rowspan="3">
<p>
</p>
</td><td width="74%">
<p align="left" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">The initial level of the underlying asset is observed and the final terms of the Notes are set.</p>
</td>
</tr>
<tr>
<td width="25%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">If the closing level of the underlying asset is equal to or greater than the coupon barrier on any observation date (including the final valuation date), UBS will pay you a contingent coupon on the applicable coupon payment date.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">The Notes will be subject to an automatic call if the closing level of the underlying asset on any observation date other than the final valuation date is equal to or greater than the initial level.</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">If the Notes are subject to an automatic call, UBS will pay you on the call settlement date a cash payment per Note equal to the principal amount plus any contingent coupon otherwise due. Following an automatic call, no further payments will be made on the Notes.</p>
</td>
</tr>
<tr>
<td width="25%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">The final level is observed on the final valuation date and the underlying return is calculated.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>If the Notes are not subject to an automatic call and the final level is equal to or greater than the downside threshold, </b>UBS will pay you a cash payment per Note equal to:</p>
<p align="center" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Principal Amount of $10</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>If the Notes are not subject to an automatic call and the final level is less than its downside threshold</b>, UBS will pay you a cash payment per Note that is less than the principal amount, if anything, equal to:</p>
<p align="center" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">$10 x (1+ Underlying Return)</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>In this scenario, you will suffer a percentage loss on your initial investment equal to the underlying return and, in extreme situations, you could lose all of your initial investment.</b>
</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 0pt; line-height: 0pt;">&nbsp;</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Investing in the Notes involves significant risks. You may lose a significant portion or all of your initial investment. Any payment on the Notes, including any repayment of principal, is subject to the creditworthiness of UBS. If UBS were to default on its obligations, you may not receive any payments owed to you under the Notes and you could lose all of your initial investment.</b>
</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>You will lose a significant portion or all of your initial investment if the Notes are not subject to an automatic call and the final level is less than the downside threshold. You may not receive any contingent coupons during the term of the Notes.</b>
</p>
<p></p>
<p></p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="66.6666666666667%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h1 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N10C50">Observation Dates(1) and Coupon Payment Dates(1)(2)</h1>
</td><td width="33.3333333333333%">
<p>&nbsp;</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="33.3333333333333%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="center" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">
<b>Observation Dates</b>
</p>
</td><td width="33.3333333333333%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="center" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">
<b>Coupon Payment Dates</b>
</p>
</td><td width="33.3333333333333%">
<p>&nbsp;</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="33.3333333333333%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="center" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">August 7, 2026</p>
</td><td width="33.3333333333333%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="center" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">August 11, 2026</p>
</td><td width="33.3333333333333%">
<p>&nbsp;</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="33.3333333333333%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="center" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">November 10, 2026</p>
</td><td width="33.3333333333333%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="center" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">November 12, 2026</p>
</td><td width="33.3333333333333%">
<p>&nbsp;</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="33.3333333333333%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="center" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">February 9, 2027</p>
</td><td width="33.3333333333333%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="center" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">February 11, 2027</p>
</td><td width="33.3333333333333%">
<p>&nbsp;</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="33.3333333333333%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="center" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">Final Valuation Date</p>
</td><td width="33.3333333333333%" style="border-bottom-color:black;border-bottom-style:solid;border-bottom-width:1pt;">
<p align="center" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;">Maturity Date</p>
</td><td width="33.3333333333333%">
<p>&nbsp;</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 0pt; line-height: 0pt;">
</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="3%">
<p style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">(1)</p>
</td><td width="97%">
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">Subject to the market disruption event provisions set forth in the accompanying product supplement.</p>
</td>
</tr>
<tr>
<td width="3%">
<p style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">(2)</p>
</td><td width="97%">
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">Two business days following each observation date, except that the coupon payment date for the final valuation date is the maturity date. If you are able to sell the Notes in the secondary market on an observation date, the purchaser of the Notes will be deemed to be the record holder on the applicable record date and therefore you will not be entitled to any payment attributable to that observation date.</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 0pt; line-height: 0pt;">&nbsp;</p>
<p></p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h1 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N10D5D">Key Risks</h1>
</td>
</tr>
</table>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>An investment in the Notes involves significant risks. Investing in the Notes is not equivalent to a hypothetical investment in the underlying asset. Some of the key risks that apply to the Notes are summarized below, but we urge you to read the more detailed explanation of risks relating to the Notes in the &ldquo;Risk Factors&rdquo; section of the accompanying product supplement. We also urge you to consult your investment, legal, tax, accounting and other advisors concerning an investment in the Notes.</b>
</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>
</p>
</td><td width="94.77%">
<p align="center" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Risks Relating to Return Characteristics</b>
</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Risk of loss at maturity</b> - The Notes differ from ordinary debt securities in that UBS will not necessarily make periodic coupon payments or repay the full principal amount of the Notes at maturity. If the Notes are not subject to an automatic call and the final level is less than the downside threshold, you will lose a percentage of your principal amount equal to the underlying return and, in extreme situations, you could lose all of your initial investment.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>The stated payout from the issuer applies only if you hold your Notes to maturity</b> - You should be willing to hold your Notes to maturity. If you are able to sell your Notes prior to an automatic call or maturity in the secondary market, you may have to sell them at a loss relative to your initial investment even if the level of the underlying asset at such time is equal to or greater than the downside threshold. All payments on the Notes are subject to the creditworthiness of UBS.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>You may not receive any contingent coupons with respect to your Notes</b> - UBS will not necessarily make periodic coupon payments on the Notes. If the closing level of the underlying asset is less than the coupon barrier on an observation date, UBS will not pay you the contingent coupon applicable to such observation date. If the closing level of the underlying asset is less than the coupon barrier on each observation date, UBS will not pay you any contingent coupons during the term of, and you will not receive a positive return on, your Notes. Generally, this non-payment of the contingent coupon coincides with a period of greater risk of principal loss on your Notes. </p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Your potential return on the Notes is limited to any contingent coupons, you will not participate in any appreciation of the underlying asset and you will not receive dividend payments on the underlying asset or have the same rights as holders of the underlying asset</b> - The return potential of the Notes is limited to the pre-specified contingent coupon rate, regardless of any appreciation of the underlying asset. In addition, your return on the Notes will vary based on the number of observation dates, if any, on which the requirements of the contingent coupon have been met prior to maturity or an automatic call. Because the Notes may be subject to an automatic call as early as the first potential call settlement date, the total return on the Notes could be less than if the Notes remained outstanding until maturity. Further, if the Notes are subject to an automatic call, you will not receive any contingent coupons or any other payment in respect of any coupon payment date after the call settlement date, and your return on the Notes could be less than if the Notes remained outstanding until maturity. As a result, the return on an investment in the Notes could be less than the return on a hypothetical direct investment in the underlying asset. In addition, as an owner of the Notes, you will not receive or be entitled to receive any dividend payments or other distributions on the underlying asset during the term of the Notes, and any such dividends or distributions will not be factored into the calculation of any payments on your Notes. Similarly, you will not have voting rights or any other rights of a holder of the underlying asset.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>A higher contingent coupon rate or lower downside threshold or coupon barrier may reflect greater expected volatility of the underlying asset, and greater expected volatility generally indicates an increased risk of loss at maturity</b> - The economic terms for the Notes, including the contingent coupon rate, coupon barrier and downside threshold, are based, in part, on the expected volatility of the underlying asset at the time the terms of the Notes are set. &ldquo;Volatility&rdquo; refers to the frequency and magnitude of changes in the level of the underlying asset. The greater the expected volatility of the underlying asset as of the trade date, the greater the expectation is as of that date that the closing level of the underlying asset could be less than the coupon barrier on the observation dates and that the final level could be less than the downside threshold and, as a consequence, indicates an increased risk of not receiving a contingent coupon and an increased risk of loss, respectively. All things being equal, this greater expected volatility will generally be reflected in a higher contingent coupon rate than the yield payable on our conventional debt securities with a similar maturity or on otherwise comparable securities, and/or a lower downside threshold and/or coupon barrier than those terms on otherwise comparable securities. Therefore, a relatively higher contingent coupon rate may indicate an increased risk of loss. Further, a relatively lower downside threshold and/or coupon barrier may not necessarily indicate that the Notes have a greater likelihood of a return of principal at maturity and/or paying contingent coupons. You should be willing to accept the downside market risk of the underlying asset and the potential to lose a significant portion or all of your initial investment.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Reinvestment risk</b> - The Notes will be subject to an automatic call if the closing level of the underlying asset is equal to or greater than the initial level on certain observation dates prior to the final valuation date, as set forth under &ldquo;Observation Dates and Coupon Payment Dates&rdquo; herein. Because the Notes could be subject to an automatic call as early as the first potential call settlement date, the term of your investment may be limited. In the event that the Notes are subject to an automatic call, there is no guarantee that you would be able to reinvest the proceeds at a comparable rate of return and/or with a comparable contingent coupon rate for a similar level of risk. In addition, to the extent you are able to reinvest such proceeds in an investment comparable to the Notes, you may incur transaction costs such as dealer discounts and hedging costs built into the price of the new securities. Generally, however, the longer the Notes remain outstanding, the less likely the Notes will be subject to an automatic call due to the decline in the level of the underlying asset and the shorter time remaining for the level of the underlying asset to recover. Such periods generally coincide with a period of greater risk of principal loss on your Notes. </p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>
</p>
</td><td width="94.77%">
<p align="center" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Risks Relating to Characteristics of the Underlying Asset</b>
</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Single equity risk</b> - The return on the Notes, which may be negative, is directly linked to the performance of the underlying asset. The level of the underlying asset can rise or fall sharply due to factors specific to the underlying asset and its issuer (the "underlying asset issuer"), such as stock or commodity price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and decisions and other events, as well as general market factors, such as general stock and commodity market volatility and levels, interest rates and economic, political and other conditions. You, as an investor in the Notes, should conduct your own investigation into the underlying asset issuer and the underlying asset for your Notes. For additional information regarding the underlying asset and the underlying asset issuer, please see &ldquo;Information About the Underlying Asset&rdquo; herein and the underlying asset issuer's SEC filings referred to in that section.<b> We urge you to review financial and other information filed periodically by the underlying asset issuer with the SEC.</b>
</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>There can be no assurance that the investment view implicit in the Notes will be successful </b>- It is impossible to predict whether and the extent to which the level of the underlying asset will rise or fall. There can be no assurance that the closing level of the underlying asset will be equal to or greater than the coupon barrier on any observation date or, if the Notes are not subject to an automatic call, that the final level will be equal to or greater than the downside threshold. The level of the underlying asset will be influenced by complex and interrelated political, economic, financial and other factors that affect the underlying asset issuer. You should be willing to accept the downside risks of owning equities in general and the underlying asset in particular, and the risk of losing a significant portion or all of your initial investment.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>There is no affiliation between the underlying asset issuer and UBS, and UBS is not responsible for any disclosure by such issuer </b>-<b> </b>We are not affiliated with the underlying asset issuer. We and our affiliates may currently, or from time to time in the future engage in business with the underlying asset issuer. However, we are not affiliated with the underlying asset issuer and are not responsible for such underlying asset issuer&rsquo;s public disclosure of information, whether contained in SEC filings or otherwise. You, as an investor in the Notes, should conduct your own investigation into the underlying asset and the underlying asset issuer. The underlying asset issuer is not involved in the Notes offered hereby in any way and has no obligation to take your interests into consideration for any reason, including when taking any corporate actions that might affect the market value of, and return on, your Notes.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>
</p>
</td><td width="94.77%">
<p align="center" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Estimated Value Considerations</b>
</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>The issue price you pay for the Notes exceeds their estimated initial value</b> - The issue price you pay for the Notes exceeds their estimated initial value as of the trade date due to the inclusion in the issue price of the underwriting discount, hedging costs, issuance and other costs and projected profits. As of the close of the relevant markets on the trade date, we have determined the estimated initial value of the Notes by reference to our internal pricing models and it is set forth in this pricing supplement. The pricing models used to determine the estimated initial value of the Notes incorporate certain variables, including the level and volatility of the underlying asset, any expected dividends on the underlying asset, prevailing interest rates, the term of the Notes and our internal funding rate. Our internal funding rate is typically lower than the rate we would pay to issue conventional fixed or floating rate debt securities of a similar term. The underwriting discount, hedging costs, issuance and other costs, projected profits and the difference in rates will reduce the economic value of the Notes to you. Due to these factors, the estimated initial value of the Notes as of the trade date is less than the issue price you pay for the Notes. </p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>The estimated initial value is a theoretical price; the actual price at which you may be able to sell your Notes in any secondary market (if any) at any time after the trade date may differ from the estimated initial value</b> - The value of your Notes at any time will vary based on many factors, including the factors described above and in &ldquo;Risks Relating to Characteristics of the Underlying Asset &mdash; Single equity risk&rdquo; above and is impossible to predict. Furthermore, the pricing models that we use are proprietary and rely in part on certain assumptions about future events, which may prove to be incorrect. As a result, after the trade date, if you attempt to sell the Notes in the secondary market, the actual value you would receive may differ, perhaps materially, from the estimated initial value of the Notes determined by reference to our internal pricing models. The estimated initial value of the Notes does not represent a minimum or maximum price at which we or any of our affiliates would be willing to purchase your Notes in any secondary market at any time.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Our actual profits may be greater or less than the differential between the estimated initial value and the issue price of the Notes as of the trade date </b>- We may determine the economic terms of the Notes, as well as hedge our obligations, at least in part, prior to the trade date. In addition, there may be ongoing costs to us to maintain and/or adjust any hedges and such hedges are often imperfect. Therefore, our actual profits (or potentially, losses) in issuing the Notes cannot be determined as of the trade date and any such differential between the estimated initial value and the issue price of the Notes as of the trade date does not reflect our actual profits. Ultimately, our actual profits will be known only at the maturity of the Notes.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>
</p>
</td><td width="94.77%">
<p align="center" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Risks Relating to Liquidity and Secondary Market Price Considerations</b>
</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>There may be little or no secondary market for the Notes</b> - The Notes will not be listed or displayed on any securities exchange or any electronic communications network. There can be no assurance that a secondary market for the Notes will develop. UBS Securities LLC and its affiliates intend, but are not required, to make a market in the Notes and may stop making a market at any time. If you are able to sell your Notes prior to maturity you may have to sell them at a substantial loss. The estimated initial value of the Notes does not represent a minimum or maximum price at which we or any of our affiliates would be willing to purchase your Notes in any secondary market at any time.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>The price at which UBS Securities LLC and its affiliates may offer to buy the Notes in the secondary market (if any) may be greater than UBS&rsquo; valuation of the Notes at that time, greater than any other secondary market prices provided by unaffiliated dealers (if any) and, depending on your broker, greater than the valuation provided on your customer account statements</b> -<b> </b>For a limited period of time following the issuance of the Notes, UBS Securities LLC or its affiliates may offer to buy or sell such Notes at a price that exceeds (i) our valuation of the Notes at that time based on our internal pricing models, (ii) any secondary market prices provided by unaffiliated dealers (if any) and (iii) depending on your broker, the valuation provided on customer account statements. The price that UBS Securities LLC may initially offer to buy such Notes following issuance will exceed the valuations indicated by our internal pricing models due to the inclusion for a limited period of time of the aggregate value of the underwriting discount, hedging costs, issuance costs and theoretical projected trading profit. The portion of such amounts included in our price will decline to zero on a straight line basis over a period ending no later than the date specified under &ldquo;Supplemental Plan of Distribution (Conflicts of Interest); Secondary Markets (if any)&rdquo;. Thereafter, if UBS Securities LLC or an affiliate makes secondary markets in the Notes, it will do so at prices that reflect our estimated value determined by reference to our internal pricing models at that time. The temporary positive differential relative to our internal pricing models arises from requests from and arrangements made by UBS Securities LLC with the selling agents of structured debt securities such as the Notes. As described above, UBS Securities LLC and its affiliates intend, but are not required, to make a market for the Notes and may stop making a market at any time. The price at which UBS Securities LLC or an affiliate may make secondary markets at any time (if at all) will also reflect its then current bid-ask spread for similar sized trades of structured debt securities. UBS Financial Services Inc. and UBS Securities LLC reflect this temporary positive differential on their customer statements. Investors should inquire as to the valuation provided on customer account statements provided by unaffiliated dealers.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Economic and market factors affecting the terms and market price of Notes prior to maturity </b>- Because structured notes, including the Notes, can be thought of as having a debt component and a derivative component, factors that influence the values of debt instruments and options and other derivatives will also affect the terms and features of the Notes at issuance and the market price of the Notes prior to maturity. These factors include the level of the underlying asset; the volatility of the underlying asset; any expected dividends on the underlying asset; the time remaining to the maturity of the Notes; interest rates in the markets; geopolitical conditions and economic, financial, political, force majeure and regulatory or judicial events; the creditworthiness of UBS; the then current bid-ask spread for the Notes and the factors discussed under &ldquo;Risks Relating to Hedging Activities and Conflicts of Interest &mdash; Potential conflicts of interest&rdquo; below. These and other factors are unpredictable and interrelated and may offset or magnify each other.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Impact of fees and the use of internal funding rates rather than secondary market credit spreads on secondary market prices</b> - All other things being equal, the use of the internal funding rates described above under &ldquo;&mdash; Estimated Value Considerations&rdquo; as well as the inclusion in the issue price of the underwriting discount, hedging costs, issuance and other costs and any projected profits are, subject to the temporary mitigating effect of UBS Securities LLC&rsquo;s and its affiliates&rsquo; market making premium, expected to reduce the price at which you may be able to sell the Notes in any secondary market.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>
</p>
</td><td width="94.77%">
<p align="center" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Risks Relating to Hedging Activities and Conflicts of Interest</b>
</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Potential conflicts of interest </b>-<b> </b>UBS and its affiliates may engage in business with the underlying asset issuer, which may present a conflict between the interests of UBS and you, as a holder of the Notes. There are also potential conflicts of interest between you and the calculation agent, which will be an affiliate of UBS. The calculation agent will determine whether the contingent coupon is payable to you on any coupon payment date, whether the Notes are subject to an automatic call and the payment at maturity of the Notes, if any, based on observed closing levels of the underlying asset. The calculation agent can postpone the determination of the terms of the Notes if a market disruption event occurs or is continuing on the trade date, any observation date or the final valuation date. As UBS determines the economic terms of the Notes, including the contingent coupon rate, downside threshold and coupon barrier, and such terms include the underwriting discount, hedging costs, issuance and other costs and projected profits, the Notes represent a package of economic terms. There are other potential conflicts of interest insofar as an investor could potentially get better economic terms if that investor entered into exchange-traded and/or OTC derivatives or other instruments with third parties, assuming that such instruments were available and the investor had the ability to assemble and enter into such instruments.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Following certain events, the calculation agent can make adjustments to the underlying asset and the terms of the Notes that may adversely affect the market value of, and return on, the Notes </b>- Following certain events affecting the underlying asset, the calculation agent may make adjustments to the initial level, coupon barrier, downside threshold and/or final level, as applicable, and any other term of the Notes and, in some instances, may replace such underlying asset. However, the calculation agent will not make an adjustment in response to every event that could affect the underlying asset. If an event occurs that does not require the calculation agent to make an adjustment, the market value of, and return on, the Notes may be materially and adversely affected. In addition, all determinations and calculations concerning any such adjustments will be made by the calculation agent. You should be aware that the calculation agent may make any such adjustment, determination or calculation in a manner that differs from that discussed in the accompanying product supplement or herein that it believes are appropriate to offset to the extent practical any change in your economic position as a  holder of the Notes resulting solely from any such event to achieve an equitable result. Following certain events relating to the underlying asset issuer, such as a reorganization event or a delisting or suspension of trading, the determination as to whether the contingent coupon is payable to you on any coupon payment date, whether the Notes are subject to an automatic call or the amount you receive at maturity may be based on the equity security of a successor to such underlying asset issuer in combination with any cash or any other assets distributed to holders of such underlying asset, if applicable, or on the common stock issued by another company. The occurrence of any such event and the consequent adjustments may materially and adversely affect the value of, and return on, the Notes. For more information, see the sections &ldquo;General Terms of the Securities &mdash; Antidilution Adjustments for Securities Linked to an Underlying Equity or Equity Basket Asset&rdquo;, &ldquo;&mdash; Reorganization Events for Securities Linked to an Underlying Equity or Equity Basket Asset&rdquo; and &ldquo;&mdash; Delisting of, Suspension of Trading in, or Change in Law Affecting, an Underlying Equity&rdquo; in the accompanying product supplement.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Potential UBS impact on price </b>-<b> </b>Trading or transactions by UBS or its affiliates in the underlying asset, listed and/or over-the-counter options, futures, exchange-traded funds or other instruments with returns linked to the performance of the underlying asset, may adversely affect the level of the underlying asset and, therefore, the market value of, and return on, the Notes. </p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Dealer incentives </b>-<b> </b>UBS and its affiliates act in various capacities with respect to the Notes. We and our affiliates may act as a principal, agent or dealer in connection with the sale of the Notes. Such affiliates, including the sales representatives, will derive compensation from the distribution of the Notes and such compensation may serve as an incentive to sell these Notes instead of other investments. We will pay total underwriting compensation in an amount equal to the underwriting discount listed on the cover hereof per Note to any of our affiliates acting as agents or dealers in connection with the distribution of the Notes. Given that UBS Securities LLC and its affiliates temporarily maintain a market making premium, it may have the effect of discouraging UBS Securities LLC and its affiliates from recommending sale of your Notes in the secondary market.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Potentially inconsistent research, opinions or recommendations by UBS</b> - UBS and its affiliates publish research from time to time on financial markets and other matters that may influence the value of, and return on, the Notes, or express opinions or provide recommendations that are inconsistent with purchasing or holding the Notes. Any research, opinions or recommendations expressed by UBS or its affiliates may not be consistent with each other and may be modified from time to time without notice. Investors should make their own independent investigation of the merits of investing in the Notes and the underlying asset.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>
</p>
</td><td width="94.77%">
<p align="center" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Risks Relating to General Credit Characteristics</b>
</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Credit risk of UBS </b>- The Notes are unsubordinated, unsecured debt obligations of UBS and are not, either directly or indirectly, an obligation of any third party. Any payment to be made on the Notes, including any repayment of principal, depends on the ability of UBS to satisfy its obligations as they come due. As a result, UBS' actual and perceived creditworthiness may affect the market value of the Notes. If UBS were to default on its obligations, you may not receive any payments owed to you under the terms of the Notes and you could lose all of your initial investment.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>The Notes are not bank deposits </b>- An investment in the Notes carries risks which are very different from the risk profile of a bank deposit placed with UBS or its affiliates. The Notes have different yield and/or return, liquidity and risk profiles and would not benefit from any protection provided to deposits.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>If UBS experiences financial difficulties, FINMA has the power to open restructuring or liquidation proceedings in respect of, and/or impose protective measures in relation to, UBS, which proceedings or measures may have a material adverse effect on the terms and market value of the Notes and/or the ability of UBS to make payments thereunder </b>- The Swiss Federal Act on Banks and Savings Banks of November 8, 1934, as amended (the &ldquo;Swiss Banking Act&rdquo;) grants the Swiss Financial Market Supervisory Authority (&ldquo;FINMA&rdquo;) broad powers to take measures and actions in relation to UBS if it concludes that there is justified concern that UBS is over-indebted or has serious liquidity problems or, after expiry of a deadline, UBS fails to fulfill the applicable capital adequacy requirements (whether on a standalone or consolidated basis). If one of these pre-requisites is met, FINMA is authorized to open restructuring proceedings or liquidation (bankruptcy) proceedings in respect of, and/or impose protective measures in relation to, UBS. The Swiss Banking Act grants significant discretion to FINMA in connection with the aforementioned proceedings and measures. In particular, a broad variety of protective measures may be imposed by FINMA, including a bank moratorium or a maturity postponement, which measures may be ordered by FINMA either on a stand-alone basis or in connection with restructuring or liquidation proceedings.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">In restructuring proceedings, FINMA, as resolution authority, is competent to approve the restructuring plan. The restructuring plan may, among other things, provide for (a) the transfer of all or a portion of UBS&rsquo; assets, debts, other liabilities and contracts (which may or may not include the contractual relationship between UBS and the holders of Notes) to another entity, (b) a stay (for a maximum of two business days) on the termination of contracts to which UBS is a party, and/or the exercise of (w) rights to terminate, (x) netting rights, (y) rights to enforce or dispose of collateral or (z) rights to transfer claims, liabilities or collateral under contracts to which UBS is a party, (c) the partial or full conversion of UBS&rsquo; debt and/or other obligations, including its obligations under the Notes, into equity (a &ldquo;debt-to-equity swap&rdquo;), and/or (d) the partial or full write-off of obligations owed by UBS (a &ldquo;write-off&rdquo;), including its obligations under the Notes. Prior to any debt-to-equity swap or write-off with respect to any Notes, outstanding equity and debt instruments issued by UBS qualifying as additional tier 1 capital or tier 2 capital must be converted or written-down, as applicable, and cancelled. The Swiss Banking Act addresses the order in which a debt-to-equity swap or a write-off of debt instruments (other than debt instruments qualifying as additional tier 1 capital or tier 2 capital) should occur: first, all subordinated obligations not qualifying as regulatory capital; second, debt instruments for loss absorbency in the course of insolvency measures (<i>Schuldinstrumente zur Verlusttragung im Falle von Insolvenzmassnahmen</i>) under the Swiss Ordinance concerning Capital Adequacy and Risk Diversification for Banks and Securities Dealers of June 1, 2012, as amended; third, all other obligations not excluded by law from a debt-to-equity swap or write-off (other than deposits), such as the Notes; and fourth, deposits to the extent in excess of the amount privileged by law. However, given the broad discretion granted to FINMA, any restructuring plan approved by FINMA in connection with restructuring proceedings with respect to UBS could provide that the claims under or in connection with the Notes will be fully or partially converted into equity or written-off, while preserving other obligations of UBS that rank <i>pari passu</i> with UBS&rsquo; obligations under the Notes. Consequently, the exercise by FINMA of any of its statutory resolution powers or any suggestion of any such exercise could materially adversely affect the rights of holders of the Notes, the price or value of their investment in the Notes and/or the ability of UBS to satisfy its obligations under the Notes and could lead to holders losing some or all of their investment in the Notes.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Once FINMA has opened restructuring proceedings with respect to UBS, it may consider factors such as the results of operations, financial condition (in particular, the level of indebtedness, potential future losses and/or restructuring costs), liquidity profile and regulatory capital adequacy of UBS and its subsidiaries, or any other factors of its choosing, when determining whether to exercise any of its statutory resolution powers with respect to UBS, including, if it chooses to exercise such powers to order a debt-to- equity swap and/or a write-off, whether to do so in full or in part. The criteria that FINMA may consider in exercising any statutory resolution power provide it with considerable discretion. Therefore, holders of the Notes may not be able to refer to publicly available criteria in order to anticipate a potential exercise of any such power and, consequently, its potential effects on the Notes and/or UBS.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">If UBS were to be subject to restructuring proceedings, the creditors whose claims are affected by the restructuring plan would not have a right to vote on, reject, or seek the suspension of the restructuring plan. In addition, if a restructuring plan with respect to UBS has been approved by FINMA, the rights of a creditor to challenge the restructuring plan or have the restructuring plan reviewed by a judicial or administrative process or otherwise (e.g., on the grounds that the plan would unduly prejudice the rights of holders of Notes or otherwise be in violation of the Swiss Banking Act) are very limited. Even if any of UBS&rsquo; creditors were to successfully challenge the restructuring plan in court, the court could only require the relevant creditors to be compensated ex post and there is currently no guidance as to on what basis such compensation would be calculated and how it would be funded. Any such challenge (even if successful) would not suspend, or result in the suspension of, the implementation of the restructuring plan.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>
</p>
</td><td width="94.77%">
<p align="center" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Risks Relating to U.S. Federal Income Taxation</b>
</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="5.23%">
<p>&bull;</p>
</td><td width="94.77%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Uncertain tax treatment </b>- Significant aspects of the tax treatment of the Notes are uncertain. You should consult your tax advisor about your tax situation. See &ldquo;What Are the Tax Consequences of the Notes?&rdquo; herein and &ldquo;Material U.S. Federal Income Tax Consequences&rdquo;, including the section &ldquo;Securities Treated as Prepaid Derivatives or Prepaid Forwards with Associated Contingent Coupons&rdquo;, in the accompanying product supplement.</p>
</td>
</tr>
</table>
<p>
</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr height="0.423333326975505cm">
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h1 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N1134C">Hypothetical Examples of How the Notes Might Perform</h1>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 0pt; line-height: 0pt;">&nbsp;</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>The below examples are based on hypothetical terms. The actual terms are indicated on the cover hereof.</b>
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">The examples below illustrate the payment upon an automatic call or at maturity for a $10 Note on a hypothetical offering of the Notes, with the following assumptions (amounts may have been rounded for ease of reference):</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Principal Amount:</p>
</td><td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$10</p>
</td>
</tr>
<tr>
<td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Term:</p>
</td><td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Approximately 1 year</p>
</td>
</tr>
<tr>
<td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Contingent Coupon Rate:</p>
</td><td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">16.53% per annum </p>
</td>
</tr>
<tr>
<td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Contingent Coupon:</p>
</td><td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$0.4133</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr height="0.317499995231628cm">
<td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Observation Dates:</p>
</td><td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Quarterly</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Initial Level:</p>
</td><td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$100.00</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Downside Threshold:</p>
</td><td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$70.00 (which is 70.00% of the Initial Level)</p>
</td>
</tr>
<tr>
<td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Coupon Barrier:</p>
</td><td width="50%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$70.00 (which is 70.00% of the Initial Level)</p>
</td>
</tr>
</table>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Example 1 &mdash; The Closing Level of the Underlying Asset is equal to or greater than the Initial Level on the Observation Date corresponding to the first potential Call Settlement Date.</b>
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Date</b>
</p>
</td><td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Closing Level</b>
</p>
</td><td width="2%">
<p>&nbsp;</p>
</td><td width="38%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Payment (per Note)</b>
</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">First Observation Date</p>
</td><td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$105.00 (<b>equal to or greater than</b> Initial Level and Coupon Barrier)</p>
</td><td width="2%">
<p>&nbsp;</p>
</td><td width="38%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$10.4133 (Call Settlement Amount)</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
</td><td width="30%">
<p align="right" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Total Payment:</p>
</td><td width="2%">
<p>&nbsp;</p>
</td><td width="38%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$10.4133 (4.133% total return)</p>
</td>
</tr>
</table>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Because the Notes are subject to an automatic call on the first potential call settlement date (which is approximately 3 months after the trade date), UBS will pay you on the call settlement date a total of $10.4133 per Note, reflecting your principal amount plus the applicable contingent coupon, for a total return of 4.133% on the Notes. You will not receive any further payments on the Notes.</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Example 2 &mdash; The Notes are NOT subject to an Automatic Call and the Final Level of the Underlying Asset is equal to or greater than the Downside Threshold and Coupon Barrier.</b>
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Date</b>
</p>
</td><td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Closing Level</b>
</p>
</td><td width="2%">
<p>&nbsp;</p>
</td><td width="38%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Payment (per Note)</b>
</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">First Observation Date</p>
</td><td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$83.30 (<b>equal to or greater than </b>Coupon Barrier; <b>less than</b> Initial Level)</p>
</td><td width="2%">
<p>&nbsp;</p>
</td><td width="38%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$0.4133 (Contingent Coupon)</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Second through Third Observation Date</p>
</td><td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Various (all <b>less than</b> Initial Level and Coupon Barrier)</p>
</td><td width="2%">
<p>&nbsp;</p>
</td><td width="38%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$0.00</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Final Valuation Date</p>
</td><td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$77.00 (<b>equal to or greater than</b> Coupon Barrier and Downside Threshold)</p>
</td><td width="2%">
<p>&nbsp;</p>
</td><td width="38%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$10.4133 (Payment at Maturity)</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
</td><td width="30%">
<p align="right" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Total Payment:</p>
</td><td width="2%">
<p>&nbsp;</p>
</td><td width="38%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$10.8266 (8.266% total return)</p>
</td>
</tr>
</table>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Because the Notes are not subject to an automatic call and the final level of the underlying asset is equal to or greater than the downside threshold, UBS will pay you a cash payment per Note at maturity equal to the principal amount. Because the final level of the underlying asset was also equal to or greater than the coupon barrier, a contingent coupon will be paid with respect to the final valuation date. At maturity, UBS will pay you a total of $10.4133 per Note (reflecting your principal amount plus the applicable contingent coupon). When added to the contingent coupon(s) of $0.4133 received in respect of the prior observation date(s), UBS will have paid you a total of $10.8266 per Note, for a total return of 8.266% on the Notes. </p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Example 3 &mdash; The Notes are NOT subject to an Automatic Call and the Final Level of the Underlying Asset is less than the Downside Threshold and Coupon Barrier.</b>
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Date</b>
</p>
</td><td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Closing Level</b>
</p>
</td><td width="2%">
<p>&nbsp;</p>
</td><td width="38%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Payment (per Note)</b>
</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">First Observation Date</p>
</td><td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$83.30 (<b>equal to or greater than </b>Coupon Barrier; <b>less than</b> Initial Level)</p>
</td><td width="2%">
<p>&nbsp;</p>
</td><td width="38%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$0.4133 (Contingent Coupon)</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Second through Third Observation Date</p>
</td><td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Various (all <b>less than</b> Initial Level and Coupon Barrier)</p>
</td><td width="2%">
<p>&nbsp;</p>
</td><td width="38%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$0.00</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Final Valuation Date</p>
</td><td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$42.00 (<b>less than</b> Coupon Barrier and Downside Threshold)</p>
</td><td width="2%">
<p>&nbsp;</p>
</td><td width="38%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$10.00 x (1 + Underlying Return) =</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$10.00 x [1 + (-58% )] = </p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$10.00 x 0.42 =</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$4.20 (Payment at Maturity)</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="30%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
</td><td width="30%">
<p align="right" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Total Payment:</p>
</td><td width="2%">
<p>
</p>
</td><td width="38%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">$4.6133 (53.867% loss)</p>
</td>
</tr>
</table>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">Because the Notes are not subject to an automatic call and the final level is less than the downside threshold, at maturity you will be exposed to the negative return of the underlying asset and UBS will pay you $4.20 per Note. When added to the contingent coupon(s) of $0.4133 received in respect of the prior observation date(s), UBS will have paid you $4.6133 per Note, for a loss on the Notes of 53.867%.</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Investing in the Notes involves significant risks. The Notes differ from ordinary debt securities in that UBS is not necessarily obligated to repay the full amount of your initial investment. If the Notes are not subject to an automatic call, you may lose a significant portion or all of your initial investment. Specifically, if the Notes are not subject to an automatic call and the final level of the underlying asset is less than its downside threshold, you will lose a percentage of your principal amount equal to the underlying return and, in extreme situations, you could lose all of your initial investment.</b>
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">&nbsp;</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: normal; line-height: normal; text-align-last: left;">
<b>Any payment on the Notes, including any payments in respect of an automatic call, contingent coupon or any repayment of principal, is subject to the creditworthiness of UBS. If UBS were to default on its obligations, you may not receive any payments owed to you under the Notes and you could lose all of your initial investment.</b>
</p>
<p style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;"></p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h1 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N11804">Information About the Underlying Asset</h1>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">All disclosures contained in this document regarding the underlying asset are derived from publicly available information. UBS has not conducted any independent review or due diligence of any publicly available information with respect to the underlying asset. <b>You should make your own investigation into the underlying asset</b>.</p>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">Included below is a brief description of the underlying asset. This information has been obtained from publicly available sources. Set forth below is a graph that illustrates the past performance for the underlying asset. The information given below is for the period indicated. We obtained the past performance information set forth below from Bloomberg Professional&reg; service (&ldquo;Bloomberg&rdquo;) without independent verification. You should not take the historical levels of the underlying asset as an indication of future performance.</p>
</td>
</tr>
</table>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">The underlying asset is registered under the Securities Act of 1933, the Securities Exchange Act of 1934 and/or the Investment Company Act of 1940, each as amended. Companies with securities registered with the SEC are required to file financial and other information specified by the SEC periodically. Information filed by the underlying asset issuer with the SEC can be reviewed electronically through a website maintained by the SEC. The address of the SEC&rsquo;s website is www.sec.gov. Information filed with the SEC by the underlying asset issuer can be located by reference to its SEC file number provided below.</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p>
</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b> Apollo Global Management, Inc.</b>
</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">According to publicly available information, Apollo Global Management, Inc. ("Apollo") is an alternative investment manager in private equity, credit and real assets with distressed investment expertise. Information filed by Apollo with the SEC can be located by reference to its SEC file number: 001-35107, or its CIK Code: 0001411494. Apollo's common stock is listed on the New York Stock Exchange under the ticker symbol "APO".</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">Information from outside sources is not incorporated by reference in, and should not be considered part of, this document or any document incorporated herein by reference. UBS has not conducted any independent review or due diligence of any publicly available information with respect to the underlying asset.</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">
<b><u>Historical Information</u></b>
</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">The graph below illustrates the performance of Apollo's common stock for the period indicated, based on the daily closing levels as reported by Bloomberg, without independent verification. UBS has not conducted any independent review or due diligence of any publicly available information obtained from Bloomberg. The solid line represents its coupon barrier and  downside threshold of $89.45, which is equal to 70.00% of the closing level on May 07, 2026. <b>Past performance of the underlying asset is not indicative of the future performance of the underlying asset during the term of the Notes.</b>
</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p align="center">
<img src="img_3.jpg" xmlns=""></p>
<p style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;"></p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h1 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N1191C">What Are the Tax Consequences of the Notes?</h1>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>The U.S. federal income tax consequences of your investment in the Notes are uncertain. There are no statutory provisions, regulations, published rulings or judicial decisions addressing the characterization for U.S. federal income tax purposes of securities with terms that are substantially the same as the Notes. Some of these tax consequences are summarized below, but we urge you to read the more detailed discussion in &ldquo;Material U.S. Federal Income Tax Consequences&rdquo;, including the section &ldquo;Securities Treated as Prepaid Derivatives or Prepaid Forwards with Associated Contingent Coupons&rdquo;, in the accompanying product supplement and to discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;), final, temporary and proposed U.S. Department of the Treasury (the &ldquo;Treasury&rdquo;) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. Tax consequences under state, local and non-U.S. laws are not addressed herein. No ruling from the U.S. Internal Revenue Service (the &ldquo;IRS&rdquo;) has been sought as to the U.S. federal income tax consequences of your investment in the Notes, and the following discussion is not binding on the IRS.</b>
</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<i>U.S. Tax Treatment.</i> Pursuant to the terms of the Notes, UBS and you agree, in the absence of a statutory or regulatory change or an administrative determination or judicial ruling to the contrary, to characterize the Notes as prepaid derivative contracts with respect to the underlying asset. If your Notes are so treated, any contingent coupon that is paid by UBS (including on the maturity date or call settlement date) should be included in your income as ordinary income in accordance with your regular method of accounting for U.S. federal income tax purposes. In determining our information reporting obligations, if any, we intend to treat the contingent coupons as ordinary income.</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">In addition, excluding amounts or proceeds attributable to any contingent coupon, you should generally recognize gain or loss upon the taxable disposition of your Notes in an amount equal to the difference between the amount you receive at such time (other than amounts or proceeds attributable to a contingent coupon or any amount attributable to any accrued but unpaid contingent coupon) and the amount you paid for your Notes. Such gain or loss should generally be short-term capital gain or loss if you have held your Notes for a period of one year or less. The deductibility of capital losses is subject to limitations. Although uncertain, it is possible that proceeds received from the taxable disposition of your Notes prior to a coupon payment date, but that could be attributed to an expected contingent coupon, could be treated as ordinary income. You should consult your tax advisor regarding this risk.</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">&nbsp;</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">We will not attempt to ascertain whether the underlying asset issuer would be treated as a &ldquo;passive foreign investment company&rdquo; (a &ldquo;PFIC&rdquo;) within the meaning of Section 1297 of the Code or as a &ldquo;United States real property holding corporation&rdquo; (a &ldquo;USRPHC&rdquo;) within the meaning of Section 897 of the Code. If any such entity were so treated, certain adverse U.S. federal income tax consequences might apply, to a U.S. holder in the case of a PFIC and to a non-U.S. holder in the case of a USRPHC, upon the taxable disposition of a Note. Both U.S. holders and non-U.S. holders should refer to information filed with the SEC or the equivalent governmental authority by any such entity and consult their tax advisors regarding the possible consequences to them in the event that any such entity is or becomes a PFIC or USRPHC.</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Based on certain factual representations received from us, our special U.S. tax counsel, Cadwalader, Wickersham &amp; Taft LLP, is of the opinion that it would be reasonable to treat your Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is possible that your Notes could alternatively be treated for tax purposes as a single contingent payment debt instrument, or pursuant to some other characterization, such that the timing and character of your income from the Notes could differ materially and adversely from the treatment described above, as described further under &ldquo;Material U.S. Federal Income Tax Consequences&rdquo;, including the section &ldquo;Securities Treated as Prepaid Derivatives or Prepaid Forwards with Associated Contingent Coupons&rdquo; in the accompanying product supplement. </b>
</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Except to the extent otherwise required by law, UBS intends to treat your Notes for U.S. federal income tax purposes in accordance with the treatment described above and under &ldquo;Material U.S. Federal Income Tax Consequences &mdash; Securities Treated as Prepaid Derivatives or Prepaid Forwards with Associated Contingent Coupons&rdquo; in the accompanying product supplement unless and until such time as the IRS and the Treasury determine that some other treatment is more appropriate.</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<i>Notice 2008-2</i>. In 2007, the IRS released a notice that may affect the taxation of holders of the Notes. According to Notice 2008-2, the IRS and the Treasury are actively considering whether the holder of an instrument such as the Notes should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is possible, however, that under such guidance, holders of the Notes will ultimately be required to accrue income currently in excess of any receipt of contingent coupons and this could be applied on a retroactive basis. The IRS and the Treasury are also considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary or capital, whether non-U.S. holders of such instruments should be subject to withholding tax on any deemed income accruals, and whether the special &ldquo;constructive ownership rules&rdquo; of Section 1260 of the Code should be applied to such instruments. <b>Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the significance, and potential impact, of the above considerations.</b>
</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
</p>
<p style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<i>Medicare Tax on Net Investment Income</i>. U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8% tax on all or a portion of their &ldquo;net investment income&rdquo;, which may include any income or gain realized with respect to the Notes, to the extent of their net investment income that when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse), $125,000 for a married individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the income tax. U.S. holders should consult their tax advisors as to the consequences of the 3.8% Medicare tax.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<i>Specified Foreign Financial Assets. </i>U.S. holders may be subject to reporting obligations with respect to their Notes if they do not hold their Notes in an account maintained by a financial institution and the aggregate value of their Notes and certain other &ldquo;specified foreign financial assets&rdquo; (applying certain attribution rules) exceeds an applicable threshold. Significant penalties can apply if a U.S. holder is required to disclose its Notes and fails to do so.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<i>Non-U.S. Holders</i>. The U.S. federal income tax treatment of the contingent coupons is unclear. Subject to the discussions below with respect to Section 871(m) of the Code and FATCA (as defined below), our special U.S. tax counsel is of the opinion that contingent coupons paid to a non-U.S. holder that provides us (and/or the applicable withholding agent) with a fully completed and validly executed applicable IRS Form W-8 should not be subject to U.S. withholding tax and we do not intend to withhold any tax on contingent coupons. However, it is possible that the IRS could assert that such payments are subject to U.S. withholding tax, or that another withholding agent may otherwise determine that withholding is required, in which case the other withholding agent may withhold up to 30% on such payments (subject to reduction or elimination of such withholding tax pursuant to an applicable income tax treaty). We will not pay any additional amounts in respect of such withholding. Subject to Section 897 of the Code, discussed above, and Section 871(m) of the Code, discussed below, gain realized from the taxable disposition or maturity of the Notes generally should not be subject to U.S. tax unless (i)<b> </b>such gain is effectively connected with a trade or business conducted by the non-U.S. holder in the U.S., (ii) the non-U.S. holder is a non-resident alien individual and is present in the U.S. for 183 days or more during the taxable year of such taxable disposition and certain other conditions are satisfied or (iii) the non-U.S. holder has certain other present or former connections with the U.S.</p>
<p>
</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<i>Section 871(m)</i>. A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section 871(m) of the Code on certain &ldquo;dividend equivalents&rdquo; paid or deemed paid to a non-U.S. holder with respect to a &ldquo;specified equity-linked instrument&rdquo; that references one or more dividend-paying U.S. equity securities or indices containing U.S. equity securities. The withholding tax can apply even if the instrument does not provide for payments that reference dividends. Treasury regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on specified equity-linked instruments that have a delta of one (&ldquo;delta one specified equity-linked instruments&rdquo;) issued after 2016 and to all dividend equivalents paid or deemed paid on all other specified equity-linked instruments issued after 2017. However, the IRS has issued guidance that states that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not apply to specified equity-linked instruments that are not delta one specified equity-linked instruments and are issued before January 1, 2027.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Based on our determination that the Notes are not &ldquo;delta-one&rdquo; with respect to the underlying asset, our special U.S. tax counsel is of the opinion that the Notes should not be delta one specified equity-linked instruments and thus should not be subject to withholding on dividend equivalents. Our determination is not binding on the IRS, and the IRS may disagree with this determination. Furthermore, the application of Section 871(m) of the Code will depend on our determinations on the date the terms of the Notes are set. If withholding is required, we will not make payments of any additional amounts.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Nevertheless, after the date the terms are set, it is possible that your Notes could be deemed to be reissued for tax purposes upon the occurrence of certain events affecting the underlying asset or your Notes, and following such occurrence your Notes could be treated as delta one specified equity-linked instruments that are subject to withholding on dividend equivalents. It is also possible that withholding tax or other tax under Section 871(m) of the Code could apply to the Notes under these rules if a non-U.S. holder enters, or has entered, into certain other transactions in respect of the underlying asset or the Notes. A non-U.S. holder that enters, or has entered, into other transactions in respect of the underlying asset or the Notes should consult its tax advisor regarding the application of Section 871(m) of the Code to its Notes in the context of its other transactions.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the Notes, you are urged to consult your tax advisor regarding the potential application of Section 871(m) of the Code and the 30% withholding tax to an investment in the Notes.</b>
</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<i>Foreign Account Tax Compliance Act</i>. The Foreign Account Tax Compliance Act (&ldquo;FATCA&rdquo;) was enacted on March 18, 2010, and imposes a 30% U.S. withholding tax on &ldquo;withholdable payments&rdquo; (i.e., certain U.S.-source payments, including interest (and original issue discount), dividends, other fixed or determinable annual or periodical gain, profits, and income, and on the gross proceeds from a disposition of property of a type which can produce U.S.-source interest or dividends) and &ldquo;passthru payments&rdquo; (i.e., certain payments attributable to withholdable payments) made to certain foreign financial institutions (and certain of their affiliates) unless the payee foreign financial institution agrees (or is required), among other things, to disclose the identity of any U.S. individual with an account of the institution (or the relevant affiliate) and to annually report certain information about such account. FATCA also requires withholding agents making withholdable payments to certain foreign entities that do not disclose the name, address, and taxpayer identification number of any substantial U.S. owners (or do not certify that they do not have any substantial U.S. owners) to withhold tax at a rate of 30%. Under certain circumstances, a holder may be eligible for refunds or credits of such taxes.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Pursuant to final and temporary Treasury regulations and other IRS guidance, the withholding and reporting requirements under FATCA will generally apply to certain &ldquo;withholdable payments&rdquo;, will not apply to gross proceeds on a sale or disposition, and will apply to certain foreign passthru payments only to the extent that such payments are made after the date that is two years after final regulations defining the term &ldquo;foreign passthru payment&rdquo; are published. If withholding is required, we (or the applicable paying agent) will not be required to pay additional amounts with respect to the amounts so withheld. Foreign financial institutions and non-financial foreign entities located in jurisdictions that have an intergovernmental agreement with the U.S. governing FATCA may be subject to different rules.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Investors should consult their tax advisors about the application of FATCA, in particular if they may be classified as financial institutions (or if they hold their Notes through a foreign entity) under the FATCA rules.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<i>Proposed Legislation. </i>In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of Notes purchased after the bill was enacted to accrue interest income over the term of the Notes despite the fact that there may be no interest payments over the term of the Notes. </p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the effect of this legislation generally would have been to require instruments such as the Notes to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</p>
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">It is not possible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of your Notes. You are urged to consult your tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your Notes.</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="justify" style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: inherit; line-height: normal; margin-left: 1pt; margin-top: 3pt; space-after: 3pt;">
<b>Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the application of U.S. federal income tax laws to their particular situations, as well as any tax consequences of the purchase, beneficial ownership and disposition of the Notes, arising under the laws of any state, local, non-U.S. or other taxing jurisdiction.</b>
</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p></p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h1 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N11B02">Supplemental Plan of Distribution (Conflicts of Interest); Secondary Markets (if any)</h1>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">We have agreed to sell to UBS Securities LLC and UBS Securities LLC has agreed to purchase, all of the Notes at the issue price to the public less the underwriting discount indicated on the cover hereof. UBS Securities LLC has agreed to resell all of the Notes to UBS Financial Services Inc. at a discount from the issue price to the public equal to the underwriting discount indicated on the cover hereof. Additionally, we or one of our affiliates will also pay a fee to LFT Securities, LLC, an entity in which an affiliate of UBS Financial Services Inc. and UBS Securities LLC has an ownership interest, for providing certain electronic platform services with respect to this offering.</p>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">
</p>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">
<b>Conflicts of Interest</b> &mdash; Each of UBS Securities LLC and UBS Financial Services Inc. is an affiliate of UBS and, as such, has a &ldquo;conflict of interest&rdquo; in this offering within the meaning of Financial Industry Regulatory Authority, Inc. (&ldquo;FINRA&rdquo;) Rule 5121. In addition, UBS will receive the net proceeds (excluding the underwriting discount) from the initial public offering of the Notes, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. Consequently, the offering is being conducted in compliance with the provisions of FINRA Rule 5121. Neither UBS Securities LLC nor UBS Financial Services Inc. is permitted to sell Notes in this offering to an account over which it exercises discretionary authority without the prior specific written approval of the account holder.</p>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">
</p>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">
<b>UBS Securities LLC and its affiliates may offer to buy or sell the Notes in the secondary market (if any) at prices greater than UBS&rsquo; internal valuation</b> &mdash; The value of the Notes at any time will vary based on many factors that cannot be predicted. However, the price (not including UBS Securities LLC&rsquo;s or any affiliates' customary bid-ask spreads) at which UBS Securities LLC or any affiliate would offer to buy or sell the Notes immediately after the trade date in the secondary market is expected to exceed the estimated initial value of the Notes as determined by reference to our internal pricing models. The amount of the excess will decline to zero on a straight line basis over a period ending no later than 6 months after the trade date, provided that UBS Securities LLC may shorten the period based on various factors, including the magnitude of purchases and other negotiated provisions with selling agents. Notwithstanding the foregoing, UBS Securities LLC and its affiliates intend, but are not required to make a market for the Notes and may stop making a market at any time. For more information about secondary market offers and the estimated initial value of the Notes, see &ldquo;Key Risks &mdash; Estimated Value Considerations&rdquo; and &ldquo;&mdash;Risks Relating to Liquidity and Secondary Market Price Considerations&rdquo; herein.</p>
<p>
</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">
<b>Prohibition on Sales to EEA Retail Investors</b> &mdash; The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (the &ldquo;EEA&rdquo;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &ldquo;MiFID II&rdquo;); or (ii) a customer within the meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129, as amended. Consequently no key information document required by Regulation (EU) No 1286/2014 (the &ldquo;EU PRIIPs Regulation&rdquo;) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation.</p>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">
</p>
<p style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">
<b>Prohibition on Sales to UK Retail Investors </b>&mdash; The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom (the &ldquo;UK&rdquo;). For these purposes, a retail investor means a person who is neither: (i) a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014  as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (&ldquo;EUWA&rdquo;) nor (ii) a qualified investor as defined in paragraph 15 of Schedule 1 to the Public Offers and Admissions to Trading Regulations 2024. Consequently no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the &ldquo;UK PRIIPs Regulation&rdquo;) for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.</p>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p></p>
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%" style="background-color: rgb(99, 132, 32); color: white; font-weight: bold; font-family: Frutiger 45 Light; font-size: 9pt; padding-left: 5pt; space-before: 0pt; space-after: 2pt; padding-before: 3pt; padding-after: 3pt;">
<h1 style="break-before: auto; font-family: Frutiger 45 Light; font-size: 8pt; font-weight: bold; line-height: normal;" id="N11B91">Validity of the Notes</h1>
</td>
</tr>
</table>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p style="font-family: Frutiger 45 Light; font-size: 1.5pt; line-height: 1.5pt;">&nbsp;</p>
<p align="justify" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; margin-left: 1pt; space-after: 3pt; text-align-last: left;">In the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP, as special counsel to the issuer, when the Notes offered by this pricing supplement have been executed and issued by the issuer and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the Notes will be valid and binding obligations of the issuer, enforceable against the issuer in accordance with their terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors' rights generally, and to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Swiss law, Fried, Frank, Harris, Shriver &amp; Jacobson LLP has assumed, without independent inquiry or investigation, the validity of the matters opined on by Homburger AG, Swiss legal counsel for the issuer, in its opinion dated April 20, 2026 filed on that date with the Securities and Exchange Commission as an exhibit to a Current Report on Form 6-K and incorporated by reference into the issuer's registration statement on Form F-3 (the "Registration Statement"). In addition, this opinion is subject to customary assumptions about the trustee's authorization, execution and delivery of the indenture and, with respect to the Notes, authentication of the Notes and the genuineness of signatures and certain factual matters, all as stated in the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP dated December 6, 2024 filed with the Securities and Exchange Commission as Exhibit 5.4 to the Registration Statement.</p>
</div>
<div style="float: left; width: 49%;"></div>
<div style="float: right; width: 49%;"></div>
<div style="margin:auto; width: 2%;">
<p></p>
</div>
<br clear="all">
<div style="width: 100%;">
<table cellspacing="0" width="100%" cellpadding="0">
<tr>
<td width="100%">
<p align="center" style="font-family: Frutiger 45 Light; font-size: 7pt; font-weight: normal; line-height: normal; padding-top: 1pt; space-before: 0pt;"></p>
</td>
</tr>
</table>
</div>

</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exhibit107-1.htm
<DESCRIPTION>EXHIBIT107-1.HTM
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ubs="http://ubsag.com/20250818">
<head>
<title>EX Filing Fees</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_027_FFD%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_ubs_ubsag.com_20250818 -->
<!-- Field: Set; Name: xdx; ID: xdx_049_20250818_20250818 -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001114446 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Arial, Helvetica, Sans-Serif">
<div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="Asof2026-05-07" id="Fact000003" name="dei:EntityCentralIndexKey">0001114446</ix:nonNumeric>
</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="Asof2026-05-07">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001114446</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2026-05-07</xbrli:startDate>
<xbrli:endDate>2026-05-07</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:unit id="USD">
<xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="Shares">
<xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="USDPShares">
<xbrli:divide>
<xbrli:unitNumerator>
<xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unitNumerator>
<xbrli:unitDenominator>
<xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unitDenominator>
</xbrli:divide>
</xbrli:unit>
<xbrli:unit id="Ratio">
<xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit>
</ix:resources>
</ix:header>
</div>
<div style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right">
<span style="font-family: times new roman; font-size: 12pt">
<b>Exhibit 107.1</b>
</span>
</div>
<div style="font: 12pt/14pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">
<b>CALCULATION OF FILING FEE TABLES</b>
</div>
<div style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 6pt; margin-bottom: 6pt">
<span id="xdx_901_effd--FormTp_c20250818__20250818_zi5qEpRRShT" style="font-family: Times New Roman, Times, Serif; font-size: 12pt">
<b>
<ix:nonNumeric contextRef="Asof2026-05-07" id="Fact000009" name="ffd:FormTp">F-3</ix:nonNumeric>
</b>
</span>
</div>
<div style="font: 12pt/14pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center">
<b>
<span id="xdx_90F_edei--EntityRegistrantName_c20250818__20250818_zCbtmmaqgB5">
<ix:nonNumeric contextRef="Asof2026-05-07" id="Fact000010" name="dei:EntityRegistrantName">UBS AG</ix:nonNumeric>
</span>
</b>
</div>
<div style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; visibility: hidden; text-indent: 0in">
<span style="visibility: hidden; font-family: Times New Roman, Times, Serif; font-size: 10pt">Submission Type: <span id="xdx_904_effd--SubmissnTp_c20250818__20250818_z5ivN8uVeBDf" style="visibility: hidden">
<ix:nonNumeric contextRef="Asof2026-05-07" id="Fact000011" name="ffd:SubmissnTp">424B2</ix:nonNumeric>
</span>
</span>
</div>
<div style="font: 10pt Times New Roman, Times, Serif; margin: 0; visibility: hidden; text-align: left">
<span id="xdx_90C_effd--FeeExhibitTp_c20250818__20250818_zGL5Me4eUZo1" style="visibility: hidden">
<ix:nonNumeric contextRef="Asof2026-05-07" id="Fact000012" name="ffd:FeeExhibitTp">EX-FILING FEES</ix:nonNumeric>
</span>
</div>
<div style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; visibility: hidden; text-indent: 0in">
<span style="visibility: hidden; font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC File No. <span id="xdx_90C_effd--RegnFileNb_c20250818__20250818_zOArwEr8Ot9" style="visibility: hidden">
<ix:nonNumeric contextRef="Asof2026-05-07" id="Fact000013" name="ffd:RegnFileNb">333-283672</ix:nonNumeric>
</span>
</span>
</div>
<div style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; visibility: hidden; text-indent: 0in">
<span style="visibility: hidden; font-family: Times New Roman, Times, Serif; font-size: 10pt">Final Prospectus: <span id="xdx_905_effd--FnlPrspctsFlg_c20250818__20250818_zKODQO5O5rnb" style="visibility: hidden">
<ix:nonNumeric contextRef="Asof2026-05-07" format="ixt:booleantrue" id="Fact000014" name="ffd:FnlPrspctsFlg">True</ix:nonNumeric>
</span>
</span>
</div>
<div style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; visibility: hidden">
<span>
<span id="xdx_90E_effd--OfferingTableNa_c20250818__20250818_zfsT2tWnwzd5">
<span id="xdx_904_effd--OffsetTableNa_c20250818__20250818_z4VegKeAZlRc" style="visibility: hidden">
<span id="xdx_90B_effd--CombinedProspectusTableNa_c20250818__20250818_zF830Ch75BHb">
<ix:nonNumeric contextRef="Asof2026-05-07" id="Fact000015" name="ffd:OfferingTableNa">
<ix:nonNumeric contextRef="Asof2026-05-07" id="Fact000016" name="ffd:OffsetTableNa">
<ix:nonNumeric contextRef="Asof2026-05-07" id="Fact000017" name="ffd:CombinedProspectusTableNa">N/A</ix:nonNumeric>
</ix:nonNumeric>
</ix:nonNumeric>
</span>
</span>
</span>
</span>
</div>
<div style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0">
<span id="xdx_908_effd--NrrtvDsclsr_c20250818__20250818_zhuY6zBSyzVh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
<ix:nonNumeric contextRef="Asof2026-05-07" escape="true" id="Fact000018" name="ffd:NrrtvDsclsr">The pricing supplement to which this Exhibit is attached is a final prospectus for the related offerings.</ix:nonNumeric>
</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maximum aggregate offering price for such offering is $<span style="display: inline-block" id="xdx_90D_effd--NrrtvMaxAggtOfferingPric_c20250818__20250818_zAMa3iCk8Kga">
<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" contextRef="Asof2026-05-07" id="Fact000019" format="ixt:numdotdecimal" decimals="0" unitRef="USD">350,000.00</ix:nonFraction>
</span>.</span>
</div>
<!-- Field: Page; Sequence: 1; Options: Last -->
<!-- Field: /Page -->
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwkAMhE/QO4R9lv4qSh8tKmKVUkR8XWyUxXZTsutPj+Qt3baIIRDCzDcjxERsaK1qZDgvyxyO2LS1tAglXpFRX9A5su0uBXdLvCljWWo7vD8wI8egY2Z+nEgnDNanMlilEM6DaBHEUwiTNIqh2Auv1zPSV1WhtkrWIHUFBVPLCq3kbkw4yjdparqh6oRsFOkUIj8c5Q/Eocs70FO+iO8G8jwT3mQYT2yYHq1zrd4WdU/CqsbG1ZmR/q/3BQhMSo8= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img_0.jpg
<DESCRIPTION>IMG_0.JPG
<TEXT>
begin 644 img_0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !9 -\# 2(  A$! Q$!_\0
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MV>M:@L-QX&TS[6+V"Q\C[,CS QA$WR&)QM!*9^6OVP_X(6_\HE/@=_V 6_\
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M%GQ\\+V/AG7M4U&2;1?(MC9R7VFLB-'+);EF,1W&15W8+(%)7G<WU=7X[?\
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M)_$K8QUY!!/4?#WX;>&?AEI=W;^%]#T?0[/5;V?5;E-.M8X([NZG<R2W#[
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M^*O[8GC#P3XZOH0T7AOPW),NFZ+(Q$@AF%K<01;]C;6$<9VDJ=\BJ-VA\2-
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MW^W%_P!CA8?^ENNU^NU?E'_P:HVMYXX^#?QX^)UY9_97^('CUWR5&6,<7GL
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M/'QP^'NN:QJ?_".>*O!]B^@6%W=2_9UN8=.TN9C;1LWE@,JWA8HN2T9Y&&R
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MB5=?M2_&;4/.T+PE=^']$:+3O#EJP*6Z"0Y:Z>.,[U52ZJ1L9U2,%N?^.'P
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M"I_$&OH?X5?!GPC\"_"L6A^"O"_A_P ):+#]RQT?3XK*W!]=D:J,^YY- :'
M?L!?L<:+^P1^R5X/^%NAR?:H_#MJ3>WNTJVHWDK&2XG()) >1FVJ2=JA5Z**
MZKXY?M/_  Y_9DT_3[OXB>./"O@>UU:1X;.;6]2BL4NG4 LJ&1@&(!!('K7=
M5POQR_9@^'/[3>GZ?:?$3P/X5\<6NDR/-9PZWIL5\EJ[ !F02*0I( !(]*"3
M^;G_ (.2/CKX+_:'_P""CQ\0^ _%6@^,-"_X1;3[;^T-'OH[RV\U&GW)OC)7
M<-PR,Y&17Z@?\$%_^"A/P*^!W_!)_P"%/A?QE\7OASX7\2:7_:_VS3-4U^VM
M;NV\S6+Z5-\;N&7=&Z,,CE6!Z&OK[_AT]^S'_P!$!^$7_A+6?_QNC_AT]^S'
M_P!$!^$7_A+6?_QN@MR35CQ+]KO_ (.+?V9_V8_!]Y-HOC*U^*'B41,;+1_#
M#&YCG?H/,N\>1&F>2=S/MR51N ?P[\*? 3]H+_@O5^VQKGC&QT"\N)/%&H!M
M1UN6&2/0O#5JFU$A\YOEQ#%M"Q*6E?:3AB6-?T>Z!_P2^_9O\+ZK#?6/P%^$
M,%Y;L'BE_P"$2L6:)@0RLNZ,[6! (8<CUKV[2-'L_#^FPV=A:V]C9VZ[(H+>
M(1QQ#T55  'TH$I);'E_[#W[(?AW]A/]ESPG\+_#+-<6'AJUV37DB!)=1N78
MO/<.!G!DD9FQD[00H.%%?AG_ ,'"'B[XC_LD_P#!9_3_ (S^&]-UC1_[)M=)
MN-$UN:QE&GWL\5N1) ),!) 5#I)&&R5+ XS7]$E4]?\ #VG^*M)FL-4L;/4K
M&X7;+;74*S0RCT96!!'U% *5F?%'[!7_  7]^ '[9/P^TN36O&&A?#'QQ(B1
M:AH'B._2R1;@@ _9KF0K%/&S9V8(D/&Y%)Q7O/Q8_P""COP$^"'A6;6?$WQ@
M^'>GV<*,X5-=M[BXGVC)$4,3-+*W^RBL>>E</\3O^"*?[*?Q=:9M7^!O@>%K
MC/F-I-L^CL22"2#:-$0<CJ,'KZFL7X;_ /!!7]D3X5ZL;W2_@CX=NIF*MMUB
M]O=9A^7./W=Y/*G<Y&W!XSG P!H?FK\5_"OC+_@YM_X*%Z)J'AW1M:\-_LU_
M#-C8?V]?VY@-U$TBO=&+/#75QL1%12?*C2-I #\K?NMX5\+Z?X(\+Z;HNDVL
M-CI>CVL5E9VT2[8[>&- D:*.P55  ]!3_#OAO3O!^AVNEZ3I]EI>FV,8BMK2
MT@6""W0=%1% 55'H !5V@384444""O/?VIOV7?!?[97P-USX=^/M*75O#>O1
MA9D5O+FMY%(:.:)^J2(P#*P],$$$@^A44 ?@1_P4Y_X)G_M*_P#!.C_@G[\0
M/#VD_&:P\>_LPQ2V1N-$U6$+JNEJVIVQMA$&C?:%G,(8PS(K9=C$N<#H/V /
M^"6W[27_  4?_8E^&.B_$#XU6WA']FE;%)=-\.: H_M+48%GD.V?$2H3OW$-
M-),%(4B/(!K]E_VIO^3??%'_ %Z?^SK5K]G#_DA'A/\ [!L7\J"N;0;^SC^S
MIX/_ &3?@OH7P_\  >CPZ'X7\.P>3:6R$LS$DL\CN>7D=RS,YY9F)KN***"0
JHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img_1.jpg
<DESCRIPTION>IMG_1.JPG
<TEXT>
begin 644 img_1.jpg
M_]C_X  02D9)1@ ! @$!7@%>  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ 50# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#TKXA>.;SP
M'96^H?V/#?64T@AW?;#$ZR$,V-OED8PO7/7MW-S5M<\3Z/H][J<^@Z2\-I \
M\BQZM(6*JI8XS;@9P/6N0_:#_P"1"L?^PI'_ .BI:[)_$NH_VUHUD_A^]L8K
MVY>*2:[:!A@02R +Y<K$-E!U&, ]\4 2^,?$.H>&M(BO--T"ZUN9YQ$UM;;M
MRJ58[SM5C@%0.G\0YKH:\I^.=Q>Z3X;LM6TS4]1LKLW:6S&VO)8T9"DC<HK!
M<Y YQGMFCXYW%[I/ANRU;3-3U&RNS=I;,;:\EC1D*2-RBL%SD#G&>V: /5J*
M\Z^)D.H:+X'N]>MM:U!-5LWB=9(IVCB.Z15*^4#L*_-_$">.2:T=2EUCQ%X&
MT'4+'5HM(^T?9KK4)S)Y>+=DS(J-@X;+#'3IUH [2O-/C'KVN^%=#L]7T76)
MK5I+E;5X/(A=""KMN^9"V?E ZXQVK/TWQ&ME\9K#1-%UY]4T34+)FD1[XW:P
MRJLA^5V9B#^['&?XOI3_ -H/_D0K'_L*1_\ HJ6@#UBN"U/Q[J]AX_M?",?A
MZTEN;Q&FMISJ3*AC&\Y8>22IQ&V0,_4UWM>3Z_\ \G*>%O\ L%O_ .@W- 'K
M%%%>8>(_%L=W\38_"]UK::-I%E;_ &B\E^U"W>XD(!6,29!4893\I!//IP >
MGT5YIX#\4-/X^\0>&(M6_M;3;>-;JQNC/YY"'9N3S,G> 7 Y)/!JC>-=:+\<
M[.TO]4U5](U6,S6D)U"8113@YV[0V",KC:<KB0#&* /6:*Y633%U'Q\TZ7NI
M1PV,*23PQ7\RPR3,1L!C#;<*J9*@ 'S!G/-<UXC\6QW?Q-C\+W6MIHVD65O]
MHO)?M0MWN)" 5C$F05&&4_*03SZ< 'I]>:7FO:[IOQPTCP[_ &Q-/I-_;273
MV\L$(V';-A0RH&P#&N,G/J31X#\4-/X^\0>&(M6_M;3;>-;JQNC/YY"'9N3S
M,G> 7 Y)/!JEK_\ R<IX6_[!;_\ H-S0!ZQ1110 4444 1SF9;>1K=$DF"DQ
MI(Y16;' + $@9[X./0UQ7A#QYJ7BGQ%JVE-H5O:)I,Q@NYOMYD(;+J-B^4-W
M*'J1QS[5W->1_"Z%;CQM\3(7+A)-1V,8W9& ,EP.&4@@^X((H ]<HKR+X;MJ
MFI>+/&VF7.N:G+86%\(8XY;EY'"AYE #L25&%YVX)P.1CF]X9U"]C^*GBCP9
M-?7MSI:6BSP&>Y=I8=RQY59,[Q_K>#G(VC'- '7>'O$.H:SJ^MV=YH%UIL.G
MS^5;W,V[;>+N<;TRH&,*#P3]X<^NC8:[I>J7]]8V-[%<7-@P2Z2,Y\IB6 !/
M3.5;CMCFO.?AA<7M]XD\?:3>ZGJ-U:6EX+: 3WDKO$F^=?E<MN4X4<@@\ YX
MK+^&6A6E[XV\?PRS:@J6^HA$,.HW$3$>9./G9'!<\#EB3U]30!Z3XQ\0ZAX:
MTB*\TW0+K6YGG$36UMNW*I5CO.U6. 5 Z?Q#FNAKRGXYW%[I/ANRU;3-3U&R
MNS=I;,;:\EC1D*2-RBL%SD#G&>V:[3QE::K>:7:KIFL1Z5&EW&]]<O)Y9^S<
M[PK8.&Y7'3IUH Z*O-/C'KVN^%=#L]7T76)K5I+E;5X/(A=""KMN^9"V?E Z
MXQVK/TWQ&ME\9K#1-%UY]4T34+)FD1[XW:PRJLA^5V9B#^['&?XOI3_V@_\
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M9P '^[CYU[X&:?\ M"7]G_PB=AIWVF'[:;Y)_L^\;_+V2KOV]<9.,^M>PT4
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M_A3'AS_G^UK_ ,#3_A1_PICPY_S_ &M?^!I_PKT6B@#SK_A3'AS_ )_M:_\
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DB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img_2.jpg
<DESCRIPTION>IMG_2.JPG
<TEXT>
begin 644 img_2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +\ +L# 2(  A$! Q$!_\0
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M>*QCDC8YYV\@@Y-6U3NK>?\ P"^K*?@O6+J_U3Q1-?&ZAC@NE"V]R^[R $Y
MP2 ,C/'6JFG_ !4L;W5;>!K-(K&ZE$,%P+V)Y"Q. 7A!WH">Y]JU?#?AG4-/
MEUY]8N;:Y;5)0Y:!2O&W:1M/3VY-8>C?#S4-.OK2WE70&TVTE\Q;E=/5KR8
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M)X/_ .A4T/\ \%T/_P 31_P@G@__ *%30_\ P70__$U/U5=Q<IR'_"7>&O\
MH8M)_P# V/\ ^*H_X2[PU_T,6D_^!L?_ ,577_\ "">#_P#H5-#_ /!=#_\
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M#_\ $T?\()X/_P"A4T/_ ,%T/_Q-'U5=PY3D/^$N\-?]#%I/_@;'_P#%4?\
M"7>&O^ABTG_P-C_^*KK_ /A!/!__ $*FA_\ @NA_^)H_X03P?_T*FA_^"Z'_
M .)H^JKN'*<A_P )=X:_Z&+2?_ V/_XJC_A+O#7_ $,6D_\ @;'_ /%5U_\
MP@G@_P#Z%30__!=#_P#$T?\ "">#_P#H5-#_ /!=#_\ $T?55W#E.0_X2[PU
M_P!#%I/_ (&Q_P#Q5'_"7>&O^ABTG_P-C_\ BJZ__A!/!_\ T*FA_P#@NA_^
M)H_X03P?_P!"IH?_ (+H?_B:/JJ[ARG(?\)=X:_Z&+2?_ V/_P"*H_X2[PU_
MT,6D_P#@;'_\577_ /"">#_^A4T/_P %T/\ \31_P@G@_P#Z%30__!=#_P#$
MT?55W#E/)/B7XCT._P#A]JEM9ZSIUQ</Y6R*&Z1V;$J$X .3P":][KG_ /A!
M/!__ $*FA_\ @NA_^)KH*VITU!60TK!1116@PHHHH **** "BBB@ HHHH \_
M\6_\E>^'7_<2_P#1"UZ!7G_BW_DKWPZ_[B7_ *(6O0* "BBB@ HHHH ****
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MF2V[G-?8_B'_ -%%_P#*);T?8_B'_P!%%_\ *);UTM%9^WJ=Q79S7V/XA_\
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M%% !57X)?\DAT+_MX_\ 1\E6JJ_!+_DD.A?]O'_H^2NO"]2HF)9_\E>\>_\
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M_P $O^20Z%_V\?\ H^2NRA-3N4MVS$L_^2O>/?\ N'_^B*Z6N:L_^2O>/?\
MN'_^B*Z6N6O_ !&)[A1116(@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ JK\$O^20Z%_V\?\ H^2K55?@E_R2'0O^WC_T?)77A>I43$L_
M^2O>/?\ N'_^B*Z6N:L_^2O>/?\ N'_^B*Z6LJ_\1B>X4445B(**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J_!+_ ))#H7_;Q_Z/DJU5
M7X)?\DAT+_MX_P#1\E=>%ZE1,2S_ .2O>/?^X?\ ^B*Z6N:L_P#DKWCW_N'_
M /HBNEK*O_$8GN%%%%8B"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "JOP2_Y)#H7_ &\?^CY*M55^"7_)(="_[>/_ $?)77A>I43$L_\
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MB%KT"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** //_ !;_ ,E>^'7_ '$O_1"UZ!7G_BW_ )*]\.O^XE_Z(6O0* "BBB@
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MZ$OQG_X*Q_\ %T?\+@M?^A+\9_\ @K'_ ,76C11]:?8.8SO^%P6O_0E^,_\
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M9_\ )7O'O_</_P#1%=+7/7_B,3W"BBBL1!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% '&_%;_DFNK_ /;'_P!')7M%>+_%;_DFNK_]L?\
MT<E>T5W87X'ZE1V/)+/_ )*]X]_[A_\ Z(KI:YJS_P"2O>/?^X?_ .B*Z6N>
MO_$8GN%%%%8B"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M.-^*W_)-=7_[8_\ HY*]HKQ?XK?\DUU?_MC_ .CDKVBN["_ _4J.QY)9_P#)
M7O'O_</_ /1%=+7-6?\ R5[Q[_W#_P#T172USU_XC$]PHHHK$04444 %%%%
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M2:ZO_P!L?_1R5[17B_Q6_P"2:ZO_ -L?_1R5[17=A?@?J5'8\DL_^2O>/?\
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M***Q$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <;\5O\
MDFNK_P#;'_T<E>T5XO\ %;_DFNK_ /;'_P!')7M%=V%^!^I4=CR2S_Y*]X]_
M[A__ *(KI:YJS_Y*]X]_[A__ *(KI:YZ_P#$8GN%%%%8B"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** .-^*W_)-=7_ .V/_HY*]HKQ?XK?
M\DUU?_MC_P"CDKVBN["_ _4J.QY)9_\ )7O'O_</_P#1%=+7-6?_ "5[Q[_W
M#_\ T172USU_XC$]PHHHK$04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!QOQ6_Y)KJ_P#VQ_\ 1R5[17B_Q6_Y)KJ__;'_ -')7M%=V%^!
M^I4=CR2S_P"2O>/?^X?_ .B*Z6N:L_\ DKWCW_N'_P#HBNEKGK_Q&)[A1116
M(@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C?BM_R375_
M^V/_ *.2O:*\7^*W_)-=7_[8_P#HY*]HKNPOP/U*CL>26?\ R5[Q[_W#_P#T
M172US5G_ ,E>\>_]P_\ ]$5TM<]?^(Q/<****Q$%%%% !1110 4444 %%%%
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M#_\ $4?\+6\:_P#0:_\ )6'_ .(H^JS[H.5GTO17S1_PM;QK_P!!K_R5A_\
MB*/^%K>-?^@U_P"2L/\ \11]5GW0<K/I>BOFC_A:WC7_ *#7_DK#_P#$4?\
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->OMFNFC3<(V925C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img_3.jpg
<DESCRIPTION>IMG_3.JPG
<TEXT>
begin 644 img_3.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" $L ?0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH _.#X]_\%L?B3\"/V@/VY/@IK/PV^V?\,]?#_1=7^$EUH/PM\1ZU
M#=7]WX9N-4E&OW>GK+;V=L+E85625K)?)\XF1O+>2/0_9Z_X*G:CXC^/O@?Q
MQ^T9\>=0T#P[?_\ !/#3/C?X[\ Z3\.+=] TZ1[J.2]UB'4EN9M4:6.,RPKI
MH@DC,2B3SGF^0_0&O_\ !+_X!>(_&G[4'CJ^\7^,$N_VL_!^G^&_B-'%J%J(
M].M;/1KC2(GTT&V)AE-O<N[&8SJ9 I"A04.?\)_^"4WP3^!WQ3\-?&OX6_%O
MX@:7XG\'_LP67P,\.:G]KTR?[)HEI.D]OJ7ES6+QR:DDL:-O=6MFQAK8@D4
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MO/&QEMM!\*RAIKA$BO%N5C6V@N))"+Q;>'Z/_9#_ &*?A9^Q=_PM#_A5NO\
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ML_\ _AF]#_\ D6@#W^BO /\ AT[_ ,$LO^D:?[/_ /X9O0__ )%H_P"'3O\
MP2R_Z1I_L_\ _AF]#_\ D6@#W^BO /\ AT[_ ,$LO^D:?[/_ /X9O0__ )%H
M_P"'3O\ P2R_Z1I_L_\ _AF]#_\ D6@#W^BO /\ AT[_ ,$LO^D:?[/_ /X9
MO0__ )%H_P"'3O\ P2R_Z1I_L_\ _AF]#_\ D6@#W^BO /\ AT[_ ,$LO^D:
M?[/_ /X9O0__ )%H_P"'3O\ P2R_Z1I_L_\ _AF]#_\ D6@#W^BO /\ AT[_
M ,$LO^D:?[/_ /X9O0__ )%H_P"'3O\ P2R_Z1I_L_\ _AF]#_\ D6@#W^BO
M /\ AT[_ ,$LO^D:?[/_ /X9O0__ )%H_P"'3O\ P2R_Z1I_L_\ _AF]#_\
MD6@#W^BO /\ AT[_ ,$LO^D:?[/_ /X9O0__ )%H_P"'3O\ P2R_Z1I_L_\
M_AF]#_\ D6@#W^BO /\ AT[_ ,$LO^D:?[/_ /X9O0__ )%H_P"'3O\ P2R_
MZ1I_L_\ _AF]#_\ D6@#W^BO /\ AT[_ ,$LO^D:?[/_ /X9O0__ )%H_P"'
M3O\ P2R_Z1I_L_\ _AF]#_\ D6@#W^BO /\ AT[_ ,$LO^D:?[/_ /X9O0__
M )%H_P"'3O\ P2R_Z1I_L_\ _AF]#_\ D6@#W^BO /\ AT[_ ,$LO^D:?[/_
M /X9O0__ )%H_P"'3O\ P2R_Z1I_L_\ _AF]#_\ D6@#W^BO /\ AT[_ ,$L
MO^D:?[/_ /X9O0__ )%H_P"'3O\ P2R_Z1I_L_\ _AF]#_\ D6@#W^BO /\
MAT[_ ,$LO^D:?[/_ /X9O0__ )%H_P"'3O\ P2R_Z1I_L_\ _AF]#_\ D6@#
MW^BO /\ AT[_ ,$LO^D:?[/_ /X9O0__ )%H_P"'3O\ P2R_Z1I_L_\ _AF]
M#_\ D6@#W^BO /\ AT[_ ,$LO^D:?[/_ /X9O0__ )%H_P"'3O\ P2R_Z1I_
ML_\ _AF]#_\ D6@#W^BO /\ AT[_ ,$LO^D:?[/_ /X9O0__ )%H_P"'3O\
MP2R_Z1I_L_\ _AF]#_\ D6@#W^BO /\ AT[_ ,$LO^D:?[/_ /X9O0__ )%H
M_P"'3O\ P2R_Z1I_L_\ _AF]#_\ D6@#W^BO /\ AT[_ ,$LO^D:?[/_ /X9
MO0__ )%H_P"'3O\ P2R_Z1I_L_\ _AF]#_\ D6@#W^BO /\ AT[_ ,$LO^D:
M?[/_ /X9O0__ )%H_P"'3O\ P2R_Z1I_L_\ _AF]#_\ D6@#W^BO /\ AT[_
M ,$LO^D:?[/_ /X9O0__ )%H_P"'3O\ P2R_Z1I_L_\ _AF]#_\ D6@#W^BO
M /\ AT[_ ,$LO^D:?[/_ /X9O0__ )%H_P"'3O\ P2R_Z1I_L_\ _AF]#_\
MD6@#W^BO /\ AT[_ ,$LO^D:?[/_ /X9O0__ )%H_P"'3O\ P2R_Z1I_L_\
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M\[^T/M5])_:^W<?)^W?:/LW'D>5@8/!_[-/PZ\#_ /"'?V+XC^($_P#P@O\
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M?VQ\6/$.H_:?MN[SO[0^U7TG]K[=Q\G[=]H^S<>1Y6!CT"B@#S_P?^S3\.O
M_P#PAW]B^(_B!/\ \(+_ &A_8G]L?%CQ#J/VG[;N\[^T/M5])_:^W<?)^W?:
M/LW'D>5@8/!_[-/PZ\#_ /"'?V+XC^($_P#P@O\ :']B?VQ\6/$.H_:?MN[S
MO[0^U7TG]K[=Q\G[=]H^S<>1Y6!CT"B@#S_P?^S3\.O _P#PAW]B^(_B!/\
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MY\,:;XV\$^([#6-&UBPAOM(U?2KQ+BUOK65!)%/#+&2DL;HRLKJ2K*P()!H
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M_P S69_[,\GY?.\[[=]HP=GV;(P>#_#G[4]E_P (=_PG_P 9/A_J?V'^T/\
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M_P"%@?V/\-+ZQ_MK?N^P_P!G^9K,_P#9GD_+YWG?;OM&#L^S9&. _P""3O\
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M^Q/[8^$_B'3OLWV+=YW]H?:K&/\ LC=M/D_;OL_VGCR/-R,^@44 >?\ @_\
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M^Q/[8^$_B'3OLWV+=YW]H?:K&/\ LC=M/D_;OL_VGCR/-R,^@44 >?\ @_\
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M^Q/[8^$_B'3OLWV+=YW]H?:K&/\ LC=M/D_;OL_VGCR/-R,^@44 >?\ @_\
M:6^'7CC_ (0[^Q?#GQ @_P"$Z_M#^Q/[8^$_B'3OLWV+=YW]H?:K&/\ LC=M
M/D_;OL_VGCR/-R,G@_\ :6^'7CC_ (0[^Q?#GQ @_P"$Z_M#^Q/[8^$_B'3O
MLWV+=YW]H?:K&/\ LC=M/D_;OL_VGCR/-R,^@44 >?\ @_\ :6^'7CC_ (0[
M^Q?#GQ @_P"$Z_M#^Q/[8^$_B'3OLWV+=YW]H?:K&/\ LC=M/D_;OL_VGCR/
M-R,G@_\ :6^'7CC_ (0[^Q?#GQ @_P"$Z_M#^Q/[8^$_B'3OLWV+=YW]H?:K
M&/\ LC=M/D_;OL_VGCR/-R,^@44 >?\ @_\ :6^'7CC_ (0[^Q?#GQ @_P"$
MZ_M#^Q/[8^$_B'3OLWV+=YW]H?:K&/\ LC=M/D_;OL_VGCR/-R,G@_\ :6^'
M7CC_ (0[^Q?#GQ @_P"$Z_M#^Q/[8^$_B'3OLWV+=YW]H?:K&/\ LC=M/D_;
MOL_VGCR/-R,^@44 ?+'[4/QQ\%_M :=\ ?@_X7T7QAIT7Q;^,^F7MAJ7B3X>
MZSI$FF1^%KA_$\JW-MJ%I ]O+<OH*6D4-P8))([N2[A6XBM9%;@_V+/#_P $
M_A;_ ,%,/C'\5OA)\)/B?HNC?M*^$O"WB&VNM6^"FO:1IJ:[I\_B2VU5)VFT
MR!-*D=(;2Z8:@T<MU-J!EC:47$8KL?BA\0?!'Q,_X+2_"?\ 9PU:'7I+_P"&
M?P(\3_$BWA_M"6'3#?7^HZ?H5E<^5',%N+F&U.NPXFC*QIJ.8R6=MGUE0!Y_
MX/\ VEOAUXX_X0[^Q?#GQ @_X3K^T/[$_MCX3^(=.^S?8MWG?VA]JL8_[(W;
M3Y/V[[/]IX\CS<C)X/\ VEOAUXX_X0[^Q?#GQ @_X3K^T/[$_MCX3^(=.^S?
M8MWG?VA]JL8_[(W;3Y/V[[/]IX\CS<C/H%% 'G_@_P#:6^'7CC_A#O[%\.?$
M"#_A.O[0_L3^V/A/XAT[[-]BW>=_:'VJQC_LC=M/D_;OL_VGCR/-R,_/6M?M
M>_!3X.?M@#]I7Q=_PF&G^$/BG^SUJ=[>WFN?#37M.NO#5MX%U"\NKJ>\L9[(
M7<$5Q#XDG*/<10*&T^!(C</J-NH^Q:^$?^"O_P#Q,/%S^!;/Y]5\;_LF?%3P
M9X7M>GVW6]<U;P1I&EVFX_+'YU_>VL/F2%8H_-WR.D:LZ@'B?_!OG^U;K.D_
M%KXC?L,^/?AGXQT2[T7PE\,+BVM]4^%?B"TNM/U=/A]IFGZK;ZI--;"'38U.
MAPBV-T(!<L\A@>Y62/;]1_MT?M+?#KQQ^S]\+?[%\.?$"#_A.OCO\/?[$_MC
MX3^(=.^S?8O'V@^=_:'VJQC_ +(W;3Y/V[[/]IX\CS<C,OPA^"?_  S?_P %
M=_BGXZ_X2;^V?^&H/ =OXD^R_8OL_P#PC7_"(1:1I'V?=O?[9]K_ +=\[?B'
MR/LNS;-YN]/"/VBOVC?B=XP_;@^-/P3^)&J_9_#>C?%GX$:9\*M,MYYFAO/[
M.\7>%]2U^Z>,R/'#<I)XMT2)I-L/GPFU5!*;69D /H+_ ()8_''P7)_P3R_9
M5\'+HOC 7?B3X,:/9:?,WP]UD6L,FFZ3;I<-=71M/(L8G,;&WFN7BCO5*M:M
M.KJ3\M_!']GWX1_M5_\ !<$_\%-]'\7_ ! T/5?"7CS4_"6D^%=0_9]U;3H=
M2L8O &D.)=3N9;&VET>Y6;6+TQS:MN:]A2T@M<1PQYD_;,^*?Q.^"O\ P:C^
M$?B9\&_B-KWA+Q)IGP(^&/\ 9OB#PSJ\UA?6GF3:%%)Y<\#+)'NCD=&VL,J[
M*>"17V#^P?XI\,?$GQU^T'\8_AUXCL-?\(^+_C1:WWA/Q5HMXEUINMVL/@WP
MS8S3VES$6BN8TO+.[MF>-F59K6:,D/&Z@ ^._P#@KW\ /%7_  5'^-?[/7A?
M]FKXM^(?AQKNK?"?XO'PY=^,?@_K$1N_-MM'TFZT_4K:]M8KC1+:XMKNZC^W
MW$'R[X?(626XMM_W?\"/VTOA+^T'X,\!>,/"/A?Q]8GX@_VK#::=K'PYU6*7
M0[[3))(-1L-7E2W>WTFY@N(9[;;<RQK--"Z6[3\$^F7'A;PQ=^)[/QM=^'+"
M76=/L+FQL-7DLT:ZMK6X>"2X@CE(WI'*]K;,Z A7:WB+ F-<?CY\4?\ @JIX
MG_9Z^#'[1'[-WAC7?"5AHUO?_%2Q'CJP\>/INN^$?&.IZY\4M1T^#8B,CR3)
MH%@($\VUN(Y;^W=!<"XC$0!ZQ_P;I?M7_#;XQ>!?C?X]\-^'_%\5M\8_VP?'
MGB'PJ)/!U[<16=K)8:5?!-1O+2.:STV3RIE51<3HLT@:.%I6&*^^O!_[2WPZ
M\<?\(=_8OASX@0?\)U_:']B?VQ\)_$.G?9OL6[SO[0^U6,?]D;MI\G[=]G^T
M\>1YN1GY1^&'[''_  S/_P %W%^)G@#7?L?P]^(G[-6K_P!B^!+:Z\NQ\/:G
MI5YX1TNX^Q64<*06EM)I]OHB#:SNS6KJVR.*!1]W4 ?)'_!1K]I;X=>./^"9
M'Q;_ +%\.?$"#_A.O@1X_P#[$_MCX3^(=.^S?8M%O?._M#[58Q_V1NVGR?MW
MV?[3QY'FY&?=_!_[2WPZ\<?\(=_8OASX@0?\)U_:']B?VQ\)_$.G?9OL6[SO
M[0^U6,?]D;MI\G[=]G^T\>1YN1GQO_@K+\&_#'[6GP*\(_L$>-K^_P!.T;X[
M?$K3_#VKZ]I4J"ZTNUTZUO/$TKPK(C(\DR: UHI;Y8FO!,5E$/D2_4E 'PY_
MP3#_ &N?V7+7XS_%G]A/X%^%/&/A_3/#'Q*-YX%\$/\ !+Q'H]KX7TC4M#LM
M7E6[:YTV)-)CGU:37I;>*]>$LI6*V7R/LT=?4?@_]I;X=>./^$._L7PY\0(/
M^$Z_M#^Q/[8^$_B'3OLWV+=YW]H?:K&/^R-VT^3]N^S_ &GCR/-R,^5?#W_A
M6/P^_P""J_Q>_P"0#H>J^.?A-\.?^>-M<>(-3CNO&_T:[N5L-/\ ]IQ;V/\
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M9\2?B5X.\-?")=*O'M+JY\2G7[*]M8X;L%4LY%2RFE6>22)$:$?O Q0'N_\
M@HC\0_$_[/7Q>_9P_:+\"?#:_P!=N[GXT6/PV\5W5F7$=CX:\3#[--).WER)
M#&NK6N@3B0JCO):QVRRQK=2!_C[]E3_@J+\&O^"F'Q3_ &6_V</B9<Z#XF^(
M7P_\>>$_$GB"^N+O3KJW\1WT_P *]=U*?4;>VB"B"YT_6=\,T:1[;2XCM2'2
M2010@'>?L!^.OB=^TI'^Q3\(?@WX-\SP-^SO\)O#_B/XS>,-8TZ:WACUN_\
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M >J:7X%\22Z_<2>*/'E[I=Q=W$FDZKIC6JQP:5=JJ*NH),)BY),;1^4H(DH
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MTZZ:;P):M<0,P)AE-O<W$)=,,8YY4SM=@0#[/HKS_P '_LG?LL?#W_A#O^$
M_9I^'^A_\*[_ +0_X5__ &/X-L;;_A&?M^[[=_9_EQ#[%]IW-YWD[/-W'?NR
M:/!_[)W[+'P]_P"$._X0#]FGX?Z'_P *[_M#_A7_ /8_@VQMO^$9^W[OMW]G
M^7$/L7VG<WG>3L\W<=^[)H ] HKS_P '_LG?LL?#W_A#O^$ _9I^'^A_\*[_
M +0_X5__ &/X-L;;_A&?M^[[=_9_EQ#[%]IW-YWD[/-W'?NR:/!_[)W[+'P]
M_P"$._X0#]FGX?Z'_P *[_M#_A7_ /8_@VQMO^$9^W[OMW]G^7$/L7VG<WG>
M3L\W<=^[)H ] HKS_P '_LG?LL?#W_A#O^$ _9I^'^A_\*[_ +0_X5__ &/X
M-L;;_A&?M^[[=_9_EQ#[%]IW-YWD[/-W'?NR:/!_[)W[+'P]_P"$._X0#]FG
MX?Z'_P *[_M#_A7_ /8_@VQMO^$9^W[OMW]G^7$/L7VG<WG>3L\W<=^[)H ]
M HKS_P '_LG?LL?#W_A#O^$ _9I^'^A_\*[_ +0_X5__ &/X-L;;_A&?M^[[
M=_9_EQ#[%]IW-YWD[/-W'?NR:/!_[)W[+'P]_P"$._X0#]FGX?Z'_P *[_M#
M_A7_ /8_@VQMO^$9^W[OMW]G^7$/L7VG<WG>3L\W<=^[)H ] HKS_P '_LG?
MLL?#W_A#O^$ _9I^'^A_\*[_ +0_X5__ &/X-L;;_A&?M^[[=_9_EQ#[%]IW
M-YWD[/-W'?NR:/!_[)W[+'P]_P"$._X0#]FGX?Z'_P *[_M#_A7_ /8_@VQM
MO^$9^W[OMW]G^7$/L7VG<WG>3L\W<=^[)H ] HKS_P '_LG?LL?#W_A#O^$
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MO^$9^W[OMW]G^7$/L7VG<WG>3L\W<=^[)H ] HKS_P '_LG?LL?#W_A#O^$
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MWG>3L\W<=^[)H ] HKS_ ,'_ +)W[+'P]_X0[_A /V:?A_H?_"N_[0_X5_\
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M_P"%=_VA_P *_P#['\&V-M_PC/V_=]N_L_RXA]B^T[F\[R=GF[COW9-'@_\
M9._98^'O_"'?\(!^S3\/]#_X5W_:'_"O_P"Q_!MC;?\ ",_;]WV[^S_+B'V+
M[3N;SO)V>;N._=DT <1_P4^_XE__  3V^,/CJS^35?!'@.^\9^%[KK]BUO0X
M_P"U]+N]I^63R;^QM9O+D#12>5LD1XV9&^/O^"!O_!';PQ^SK^RG\#_V@OVC
MO ?BW1?BWX:O_%OB6T\-ZYJ"11Z)=:_%9:>9'MXD5UD_LG2[0>1.[-#)>W?F
M1B58EM_KWXZ_\$XOV6/BG^S'JO[.7@#X'_#_ ,$^5X#\4>&_A_K.C^ +$?\
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M_P#L?P;8VW_",_;]WV[^S_+B'V+[3N;SO)V>;N._=DU\(_LH_LG?LL?LE?\
M!PG\4/A9X _9I^']O_PF/P(T3XD?#^_T?P;8Z?\ \*]^R7$WAZ^L-/2.(^7]
MO\YKF::%H,Y,;QRY,E 'Z75\(_L]_L<?\+Q_:%\'?\%"]+UW['XM\/?M*_$W
M_A9)%U]GA\3Z99-XB\(Z-YL,<)6:YT^UMM.@MLM$D<-QJDIWSW<K2_5W@_\
M9._98^'O_"'?\(!^S3\/]#_X5W_:'_"O_P"Q_!MC;?\ ",_;]WV[^S_+B'V+
M[3N;SO)V>;N._=DUXQ_P3=_9Z^ 5C\#]*UBQ^!W@^&[^&OQG^+%A\.;J+PS:
MK)X5M9?&VNVLMOIK"/-C$]O&D+)#L5HT5""H H ^IZ\ _P""3O\ RBR_9I_[
M-_\ !O\ Z8[.N_\ !_[)W[+'P]_X0[_A /V:?A_H?_"N_P"T/^%?_P!C^#;&
MV_X1G[?N^W?V?Y<0^Q?:=S>=Y.SS=QW[LFN _P""3O\ RBR_9I_[-_\ !O\
MZ8[.@#W^BBB@ HHHH **** "OD#X*_\ )T_[*'_9H'C+_P!+OA]7U_7R!\%?
M^3I_V4/^S0/&7_I=\/J /K^BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+10_;]%% 'RW\.?CM\(?V9?$?[8GQZ^/7CZP\,>$?#'QHL+S6];U)R(X(_\
MA O!ZJH507ED=V2..)%:261TC16=U4_'W[ OQ,U?XI_&&S3QUK>O:G8?%O\
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M/S=D:)&JHH![O7@'_!)W_E%E^S3_ -F_^#?_ $QV=>_UX!_P2=_Y19?LT_\
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M?VA_;?\ ;&F^'D_X2W[3N\G^T/LNE0^5]ER/)^P_8]VT>?\ :.<@'H%%>?\
M@_X-_$7PS_PAW]M?M8_$#Q#_ ,(Q_:']M_VQIOAY/^$M^T[O)_M#[+I4/E?9
M<CR?L/V/=M'G_:.<G@_X-_$7PS_PAW]M?M8_$#Q#_P (Q_:']M_VQIOAY/\
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M.[R?[0^RZ5#Y7V7(\G[#]CW;1Y_VCG(!Z!17G_@_X-_$7PS_ ,(=_;7[6/Q
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MI4/E?9<CR?L/V/=M'G_:.<G@_P"#?Q%\,_\ "'?VU^UC\0/$/_",?VA_;?\
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M.[R?[0^RZ5#Y7V7(\G[#]CW;1Y_VCG(!Z!17G_@_X-_$7PS_ ,(=_;7[6/Q
M\0_\(Q_:']M_VQIOAY/^$M^T[O)_M#[+I4/E?9<CR?L/V/=M'G_:.<G@_P"#
M?Q%\,_\ "'?VU^UC\0/$/_",?VA_;?\ ;&F^'D_X2W[3N\G^T/LNE0^5]ER/
M)^P_8]VT>?\ :.<@'H%%>?\ @_X-_$7PS_PAW]M?M8_$#Q#_ ,(Q_:']M_VQ
MIOAY/^$M^T[O)_M#[+I4/E?9<CR?L/V/=M'G_:.<G@_X-_$7PS_PAW]M?M8_
M$#Q#_P (Q_:']M_VQIOAY/\ A+?M.[R?[0^RZ5#Y7V7(\G[#]CW;1Y_VCG(!
M^?'A#Q!^U+\6O^#ACQ3\&_AK\/O-^%'P@^+,?CWXH^(/[6L5VWVL_"RST71U
M\B4+<GRVM;]<P-(K?;LRHGDQN?U'KYU^$W[&_P ;/A]^V%=?M!>)?VO_ !CX
MCT8_#71/#UW;:I9:"EUXJNK34/$ERSZHMKH\"0QVZ:Q:BV.GO:L[0R?:5E !
MD]*\'_!OXB^&?^$._MK]K'X@>(?^$8_M#^V_[8TWP\G_  EOVG=Y/]H?9=*A
M\K[+D>3]A^Q[MH\_[1SD ] HKS_P?\&_B+X9_P"$._MK]K'X@>(?^$8_M#^V
M_P"V--\/)_PEOVG=Y/\ :'V72H?*^RY'D_8?L>[://\ M'.3P?\ !OXB^&?^
M$._MK]K'X@>(?^$8_M#^V_[8TWP\G_"6_:=WD_VA]ETJ'ROLN1Y/V'['NVCS
M_M'.0#T"BO/_  ?\&_B+X9_X0[^VOVL?B!XA_P"$8_M#^V_[8TWP\G_"6_:=
MWD_VA]ETJ'ROLN1Y/V'['NVCS_M'.3P?\&_B+X9_X0[^VOVL?B!XA_X1C^T/
M[;_MC3?#R?\ "6_:=WD_VA]ETJ'ROLN1Y/V'['NVCS_M'.0#T"BO/_!_P;^(
MOAG_ (0[^VOVL?B!XA_X1C^T/[;_ +8TWP\G_"6_:=WD_P!H?9=*A\K[+D>3
M]A^Q[MH\_P"T<Y/!_P &_B+X9_X0[^VOVL?B!XA_X1C^T/[;_MC3?#R?\);]
MIW>3_:'V72H?*^RY'D_8?L>[://^T<Y /0**\_\ !_P;^(OAG_A#O[:_:Q^(
M'B'_ (1C^T/[;_MC3?#R?\);]IW>3_:'V72H?*^RY'D_8?L>[://^T<Y/!_P
M;^(OAG_A#O[:_:Q^('B'_A&/[0_MO^V--\/)_P );]IW>3_:'V72H?*^RY'D
M_8?L>[://^T<Y /0**\_\'_!OXB^&?\ A#O[:_:Q^('B'_A&/[0_MO\ MC3?
M#R?\);]IW>3_ &A]ETJ'ROLN1Y/V'['NVCS_ +1SD\'_  ;^(OAG_A#O[:_:
MQ^('B'_A&/[0_MO^V--\/)_PEOVG=Y/]H?9=*A\K[+D>3]A^Q[MH\_[1SD ]
M HKS_P '_!OXB^&?^$._MK]K'X@>(?\ A&/[0_MO^V--\/)_PEOVG=Y/]H?9
M=*A\K[+D>3]A^Q[MH\_[1SD\'_!OXB^&?^$._MK]K'X@>(?^$8_M#^V_[8TW
MP\G_  EOVG=Y/]H?9=*A\K[+D>3]A^Q[MH\_[1SD ] HKS_P?\&_B+X9_P"$
M._MK]K'X@>(?^$8_M#^V_P"V--\/)_PEOVG=Y/\ :'V72H?*^RY'D_8?L>[:
M//\ M'.3P?\ !OXB^&?^$._MK]K'X@>(?^$8_M#^V_[8TWP\G_"6_:=WD_VA
M]ETJ'ROLN1Y/V'['NVCS_M'.0#T"BO/_  ?\&_B+X9_X0[^VOVL?B!XA_P"$
M8_M#^V_[8TWP\G_"6_:=WD_VA]ETJ'ROLN1Y/V'['NVCS_M'.3P?\&_B+X9_
MX0[^VOVL?B!XA_X1C^T/[;_MC3?#R?\ "6_:=WD_VA]ETJ'ROLN1Y/V'['NV
MCS_M'.0#T"O-?B/^R?\ "'XK_M*_#/\ :K\;6=_<^*/A'8:];^"ECOC':VTF
MKPVUO=7$D:@&6006[1(&8QJMS*Q1G$3Q6O!_P;^(OAG_ (0[^VOVL?B!XA_X
M1C^T/[;_ +8TWP\G_"6_:=WD_P!H?9=*A\K[+D>3]A^Q[MH\_P"T<Y/!_P &
M_B+X9_X0[^VOVL?B!XA_X1C^T/[;_MC3?#R?\);]IW>3_:'V72H?*^RY'D_8
M?L>[://^T<Y /F#_ ((L?LGZ?:?\$*OA7^S+\>K.PUO1O'?PUU&XUNQTV^N$
MCN=(\0SW=^MN95$4L<GV/44CD*$%) ^QV 5S]2?LM?!/_AFG]F/X<_LY?\)-
M_;7_  @'@/2/#?\ ;/V+[-]O^PV45K]H\G>_E;_*W[-[[=V-S8R>>_9__90O
M?V<OAI\+/@[X+_:3\?WOAKX6Z%+HT&F:M;Z&X\16(A$%E#J$D6F1R#[%&J+"
MUHUL[^6#<M<DL6W/!_P;^(OAG_A#O[:_:Q^('B'_ (1C^T/[;_MC3?#R?\);
M]IW>3_:'V72H?*^RY'D_8?L>[://^T<Y /0*\ _X)._\HLOV:?\ LW_P;_Z8
M[.N_\'_!OXB^&?\ A#O[:_:Q^('B'_A&/[0_MO\ MC3?#R?\);]IW>3_ &A]
METJ'ROLN1Y/V'['NVCS_ +1SG@/^"3O_ "BR_9I_[-_\&_\ ICLZ /?Z***
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M/_$D-;_^8Z@#WJJ'B/Q3X8\':?'JWB[Q'8:5:37]K8Q7.I7B01O=75Q';6T
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MJBO!?^%B?\%0/^C/O@)_XDAK?_S'4?\ "Q/^"H'_ $9]\!/_ !)#6_\ YCJ
M/>J*\%_X6)_P5 _Z,^^ G_B2&M__ #'4?\+$_P""H'_1GWP$_P#$D-;_ /F.
MH ]ZHKP7_A8G_!4#_HS[X"?^)(:W_P#,=1_PL3_@J!_T9]\!/_$D-;_^8Z@#
MWJBO!?\ A8G_  5 _P"C/O@)_P")(:W_ /,=1_PL3_@J!_T9]\!/_$D-;_\
MF.H ]ZHKP7_A8G_!4#_HS[X"?^)(:W_\QU'_  L3_@J!_P!&?? 3_P 20UO_
M .8Z@#WJBO!?^%B?\%0/^C/O@)_XDAK?_P QU'_"Q/\ @J!_T9]\!/\ Q)#6
M_P#YCJ />J*\%_X6)_P5 _Z,^^ G_B2&M_\ S'4?\+$_X*@?]&?? 3_Q)#6_
M_F.H ]ZHKP7_ (6)_P %0/\ HS[X"?\ B2&M_P#S'4?\+$_X*@?]&?? 3_Q)
M#6__ )CJ />J*\%_X6)_P5 _Z,^^ G_B2&M__,=1_P +$_X*@?\ 1GWP$_\
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MJ/[*'C2WO+RRDMUCTN,3>!)1<SB65':(O$D $*RR>9<Q$H(A++& ?9]%>?\
M@_XR?$7Q-_PAW]M?LG?$#P]_PD_]H?VW_;&I>'G_ .$2^S;O)_M#[+JLWF_:
ML#R?L/VS;N'G_9^<'@_XR?$7Q-_PAW]M?LG?$#P]_P )/_:']M_VQJ7AY_\
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M?[0^RZK-YOVK \G[#]LV[AY_V?G!X/\ C)\1?$W_  AW]M?LG?$#P]_PD_\
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M[-N\G^T/LNJS>;]JP/)^P_;-NX>?]GYP >@45Y_X/^,GQ%\3?\(=_;7[)WQ
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MDDUO44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M -C^,K&Y_P"$F^P;OMW]G^7*?MOV;:WG>3O\K:=^W!H\'_M8_LL?$+_A#O\
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M -C^,K&Y_P"$F^P;OMW]G^7*?MOV;:WG>3O\K:=^W!H\'_M8_LL?$+_A#O\
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M -C^,K&Y_P"$F^P;OMW]G^7*?MOV;:WG>3O\K:=^W!H\'_M8_LL?$+_A#O\
MA /VEOA_KG_"Q/[0_P"%?_V/XRL;G_A)OL&[[=_9_ERG[;]FVMYWD[_*VG?M
MP: /0**\_P#!_P"UC^RQ\0O^$._X0#]I;X?ZY_PL3^T/^%?_ -C^,K&Y_P"$
MF^P;OMW]G^7*?MOV;:WG>3O\K:=^W!H\'_M8_LL?$+_A#O\ A /VEOA_KG_"
MQ/[0_P"%?_V/XRL;G_A)OL&[[=_9_ERG[;]FVMYWD[_*VG?MP: /0**\_P#!
M_P"UC^RQ\0O^$._X0#]I;X?ZY_PL3^T/^%?_ -C^,K&Y_P"$F^P;OMW]G^7*
M?MOV;:WG>3O\K:=^W!H\'_M8_LL?$+_A#O\ A /VEOA_KG_"Q/[0_P"%?_V/
MXRL;G_A)OL&[[=_9_ERG[;]FVMYWD[_*VG?MP: /0**\_P#!_P"UC^RQ\0O^
M$._X0#]I;X?ZY_PL3^T/^%?_ -C^,K&Y_P"$F^P;OMW]G^7*?MOV;:WG>3O\
MK:=^W!H\'_M8_LL?$+_A#O\ A /VEOA_KG_"Q/[0_P"%?_V/XRL;G_A)OL&[
M[=_9_ERG[;]FVMYWD[_*VG?MP: /0**\_P#!_P"UC^RQ\0O^$._X0#]I;X?Z
MY_PL3^T/^%?_ -C^,K&Y_P"$F^P;OMW]G^7*?MOV;:WG>3O\K:=^W!H\'_M8
M_LL?$+_A#O\ A /VEOA_KG_"Q/[0_P"%?_V/XRL;G_A)OL&[[=_9_ERG[;]F
MVMYWD[_*VG?MP: /0**\_P#!_P"UC^RQ\0O^$._X0#]I;X?ZY_PL3^T/^%?_
M -C^,K&Y_P"$F^P;OMW]G^7*?MOV;:WG>3O\K:=^W!H\'_M8_LL?$+_A#O\
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M0/$,4FFRHDANM(U>SU:V0ET<>6T]E$L@ #&-G"LC$.OB_P#P4Q\&_P#"NO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC_@JC^UO:0O<0P)+<_ KPY&K2RR+%%&"W@< L\CHBKU9F4#)(%6/^$,^(O\
MTD__ &O_ /PPGA[_ .8:O6/A_P#M7^!OC9XVTSP-J?P3\4:?H.OW%[/X&\:>
M)(-,;1/%$NFW*O')I[Q7DLKM*D;:A:-)#&9[:VDNHLI$6%CPW^V!INJ?%CPU
M\+?%WP#^)'A*+QM]L7P3XE\2Z);)I^L2V\!NO(*P7,MSI\\EJDUPD-_!:R%+
M>92JRQM$ #Q__A#/B+_TD_\ VO\ _P ,)X>_^8:C_A#/B+_TD_\ VO\ _P ,
M)X>_^8:O:_"O[4D6N>.=$\)>*O@3X\\(V7BN\EM/!WB'Q1:6$5OK5PEK/>+"
MMM%>27UF[VEM<W 6]MK8H(&CE$<Q2%O5* /D#_A#/B+_ -)/_P!K_P#\,)X>
M_P#F&H_X0SXB_P#23_\ :_\ _#">'O\ YAJ^OZ* /D#_ (0SXB_])/\ ]K__
M ,,)X>_^8:C_ (0SXB_])/\ ]K__ ,,)X>_^8:OK^B@#Y _X0SXB_P#23_\
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M>\3>+WT8?VOM\[R[6RATW4[[['8VNYQ%;.XV_:&D9[FXFN[B3U^BB@ HHHH
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M?"^TLX9=4E\-:QX<5/%]PX):QN$OM6MI8M.B&T2PF/-Z[&*3;:1RQZA]!T4
M?+'Q^^%7QRN;CXV_ ?P3\$M8\0:%\??LN_Q]9:KI<%IX6^W:5:^']0^TVUQ>
M1W-Q]DM;"/4$\A&^TM<FV_<F/SFZ3]HWQ#\;?&/Q+E^%E_\ LB>//%'POM+.
M&75)?#6L>'%3Q?<."6L;A+[5K:6+3HAM$L)CS>NQBDVVD<L>H?0=% 'RQ^U5
M^RC^U3XR\;Z]\2?@]\5/!]U_PD/C#P%)'I&M>!)Y;O3--T76K2]5!=)J]M#-
M!!.^HW[(8!<3+<26ZS<6YB^IZ** "BBB@ HHHH **** "O*_VI_''Q_\,:!I
M7A_X _!SQ)XAN-;O'AUOQ!X;NM%%QX=LU3+3PP:M>6\5Q=2$B.$-OAB)>:5)
M1$MK<^J44 ?.#^$/&GPUU+X7?'+X3?LH>,)(M#T?Q'X;UOX<OKFC'6[2'5+F
MTO9-7FNY]4:VO9WNM)B,NZZ>:<ZJ]Q)(98I(Y*=G%^U7\%?V;O#?A+X?? ;Q
M)?\ B7QMXDUO7_&LWAO4=!EN/ PU74;K5KBUA&I7T%OJ%U#)>FSAF^:W)A>Z
MDB=46RN/INB@#YP\9_"+X;:U\)_!<?BC_@F#_P )OIVG?VBJ^%/%'_".:IK^
MB7,\ZN]T[ZA>O:W/VMDDGN;D7[W+RO TB3/+,\'8?L%?"SQ]\%OV3_"GPW^)
M/AW^P]1L/MTEMX:_X2:76?\ A']/FO[B>QTC[;+\UQ]BLY+>TWC*?Z-A&9 K
M'U^B@ HHHH **** "BBB@ JGXAU.]T70+[6=-\/7FKW%I9RS6^DZ<\*W%ZZH
M66"(SR1Q!W("J9)$0%AN=1EA<HH ^6-$^&WQ@_:K\ _$3PI^T7\ _&'@+Q=X
M^^&^K^'XO$^LW6A:AI/A>TO8A#_9FG16.J2SR\LD\UQ)'"U[):AI&@CCLK2V
MZ3X>:I\?_B;\7K+]HKXH_LI>)/ UQX'^%>H:;:^%9_$6BZC<>(=3U.XL;FZM
M[2:WO?*C2W.CV\<<MR8!<'4,LMN(&+_0=% 'RQHGPV^,'[5?@'XB>%/VB_@'
MXP\!>+O'WPWU?P_%XGUFZT+4-)\+VE[$(?[,TZ*QU26>7EDGFN)(X6O9+4-(
MT$<=E:6U/]C[X&^.="_:<7XTVO[&UY\%-+F^%8TSQU;ZCX\M=3N/%WB&2]AG
IBN95LKB=;Y[18[\-JMXR7MR=4.Y"%8CZSHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>May 07, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001114446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">UBS AG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-283672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">

N/A

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">
N/A
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>May 07, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text">The pricing supplement to which this Exhibit is attached is a final prospectus for the related offerings.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 350,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>12</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="exhibit107-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exhibit107-1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exhibit107-1.htm">exhibit107-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exhibit107-1.htm": {
   "dts": {
    "inline": {
     "local": [
      "exhibit107-1.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 12,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 1,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 10,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Asof2026-05-07",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit107-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Asof2026-05-07",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit107-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "Asof2026-05-07",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit107-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Asof2026-05-07",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit107-1.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001114446-26-002945-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001114446-26-002945-xbrl.zip
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2      $  0 ^    6P@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>exhibit107-1_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="Asof2026-05-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001114446</identifier>
        </entity>
        <period>
            <startDate>2026-05-07</startDate>
            <endDate>2026-05-07</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="Asof2026-05-07" id="Fact000003">0001114446</dei:EntityCentralIndexKey>
    <ffd:FormTp contextRef="Asof2026-05-07" id="Fact000009">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="Asof2026-05-07" id="Fact000010">UBS AG</dei:EntityRegistrantName>
    <ffd:SubmissnTp contextRef="Asof2026-05-07" id="Fact000011">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="Asof2026-05-07" id="Fact000012">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:RegnFileNb contextRef="Asof2026-05-07" id="Fact000013">333-283672</ffd:RegnFileNb>
    <ffd:FnlPrspctsFlg contextRef="Asof2026-05-07" id="Fact000014">true</ffd:FnlPrspctsFlg>
    <ffd:OfferingTableNa contextRef="Asof2026-05-07" id="Fact000015">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="Asof2026-05-07" id="Fact000016">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="Asof2026-05-07" id="Fact000017">N/A</ffd:CombinedProspectusTableNa>
    <ffd:NrrtvDsclsr contextRef="Asof2026-05-07" id="Fact000018">The pricing supplement to which this Exhibit is attached is a final prospectus for the related offerings.</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="Asof2026-05-07"
      decimals="0"
      id="Fact000019"
      unitRef="USD">350000.00</ffd:NrrtvMaxAggtOfferingPric>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
